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INTRODUCTION 
Diabetes mellitus is a chronic metabolic dysregulation of glucose. It is 
a world-wide problem of increasing importance. It affects approximately 285 
million people and likely to rise to 438 million by 2030. [1,17] .In Asia, where 
two thirds of the world’s diabetic patients live , the type 2 diabetes  accounts 
for  90% of the cases[2].Population based analysis states that the prevalence of 
diabetes in India was 31.7 million in 2000 and will rise to 79.4 million in 
2030.[1] 
Cutaneous infection accounts for 20-50% of the skin manifestation 
among the diabetic patients due to poor glycaemic control [2-4 ,17].More often 
these cutaneous signs heightens the suspicion of a physician regarding the 
diagnosis of the disease [5,6].  
The fungal infection is the commonest cutaneous infection in diabetic 
patients. Moreover the prevalence of superficial mycoses namely 
onychomycosis and tinea pedis is 75% in diabetic patients especially in type 
2. [7-9] 
The relative occurrence of the etiological agents of these superficial 
mycotic infections varies among countries[10]. Hence this study was conducted 
to know the prevalence and the causative agents in our region. 
Diabetes is often  associated with various serious complications, in 
particular diabetic foot ulcers .This causes considerable morbidity, disability 
and also the leading cause for foot amputations[94] and hospitalization[1,11,30]. 
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Onychomycosis and tinea pedis are the main predisposing factors for 
the development of these dreadful complications since it  disrupts the skin 
integrity and  allows the entry of secondary pathogens (bacteria). [1,12]. 
Further the condition is associated with secondary immunodeficiency [12], 
Peripheral neuropathy, arterial insuffiency, retinopathy , minor trauma and  
obesity [1,13] which also acts as major risk factors. 
Hence early detection of superficial mycoses especially tinea pedis and 
onychomycosis of toe nails which are not commonly  noticed by the patient 
and timely, adequate dosage of antifungal agents with good glycaemic control 
can save the limb. 
Skin and nail infections are more common in diabetes [14]. The 
commonest causative agent are the dermatophytes (57% ) [7] which constitute 
a group of superficial fungal infection of keratinized tissue viz the epidermis, 
hair and nail [15].  Although dermatophyte infections are not more common in 
the diabetic population when compared to normal populations, they are of 
special concern because of the secondary complications.[16]. 
Candida species constitute 28% of cutaneous infection [7] and its 
incidence is high in diabetes because of the decrease in the β globulin, an anti 
candidial factor [17]. Infections with candida species, correlates well with the 
increased blood glucose levels and thus it helps in identifying any 
undiagnosed diabetes mellitus cases [Orman 2001] [17]. 
Several candida species are involved in human infections. Among 
these, Candida albicans is the most common species. However during the past 
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decade, there is an emergence of non albicans candida species especially 
among the diabetic patients due to immunosuppression [26]. 
Most common non-albicans isolate were C.parapsilosis, C.glabratra 
and C.tropicalis.Candida albicans and non albicans species though related, 
they differ in their epidemiology, virulence factor and antifungal 
susceptibility pattern. The inappropriate use of antifungal drugs and easy 
availability of the counter drugs in countries worldwide has predisposed to 
the development of resistance to antifungal drugs. 
Hence isolation and anti-fungal susceptibility testing of these isolates 
will help to choose the appropriate sensitive agents thereby clear the infection 
and prevents secondary complications. 
Apart from these agents, uncommon non dermatophyte moulds can also 
cause 2-7% of the superficial fungal infections in diabetic patients. These 
includes Aspergillus spp,Fusarium spp,Scytalidium spp,Acremonium spp and 
Rhizopus spp [57] 
Thus diabetic patients due to their immunosuppressive states are prone 
for frequent fungal infections of the skin and nails. Hence their early 
diagnosis, isolation of the causative agents[73] can prevent major 
complicatons. Antifungal susceptibility testing in these patients can help to 
identify the emergence of any resistance patterns. 
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REVIEW OF LITERATURE 
HISTORY 
Mycology ,the study of fungi came into existence before bacteriology, 
in 1677 when Hooks  studied the yellow spots on the leaves of Demask rose 
with the help of a magnifying lens and found the filamentous 
organism.Subsequent studies were carried out by Malphigi ( 1686);Mitchelli 
(1729) and Linnaeus (1752).[1,18] 
 The lesion produced tends to creep in a circular or ring form. For this 
reason, the Greeks named the disease herpes-a term which still persists[19] and 
the Romans named the disease as ‘Tinea’,which means, a small insect 
larva.This name is still being used to clinically describe the lesion.[19] The 
English word, “Ringworm”, is a combination of  meanings in Greek and Latin 
The chronic inflammatory diseases in scalp with loss of hair and 
formation of folded, crusted scutula have been recognised in central Europe 
and the Mediterrean area since classical times. 
In 1834, Remak examined materials from favus and noted the presence 
of filaments resembling mould. He tried to reproduce the disease by rubbing 
the organism on his skin, but failed ..Later Schoenlein in 1839 described the 
filaments as being those of moulds and concluded that favus was a disease of 
plants.[18] 
In 1841 David Gruby, published a paper in which he described the 
isolation of fungus of favus on potato slices and production of the disease by 
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inoculating onto normal skin. Thus he was the first to establish the role of 
microorganism in the causation of favus. In addition he described the  
dermatophyte, Microsporum audouinii from tinea capitis and recognised the 
endothrix form of Trichophytons [20] 
Malmsten defined the genus Trichophyton and T.tonsurans. 
T.mentagrophytes was defined in 1847 by Charles Robin who was the first to 
discuss the topical therapy for dermatophyte infections. 
Domenico Majocchi was the first to describe the variant of tinea 
corporis popularly called as Majocchi’s granuloma,a dermal and subcutaneous 
tissue infection caused by dermatophytes and he named it as ‘Granuloma 
Tricofitico” in 1883.[20] 
By 1890, Sabouraud, published his systematic and scientific studies on 
dermatophytoses. His book Les Teignes is considered a classic in medical 
literature where he classified the dermatophyte into three 
genera,Microsporum,Trichophyton,and Epidermophyton along with the genus 
Achorion based on clinical rather than on botanical observation[20]  
In the 1920’s Hopkins and Benham began their scientific study in 
medical mycology and Rhoda Benham was called as the founder of modern 
medical mycology. The laboratory at Columbia University was one of the first 
to study clinical mycology systematically. 
In 1925 Baltimore a Physicist, and Robert W.Wood invented Wood’s 
lamp   which was used for detection of fungal infection of hair.[20] 
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In 1934, Chester Emmons redefined the dermatophytes according to the 
botanical rules of nomenclature and taxonomy.Lucille George identified 
several organisms based on physiological characters and nutritional 
requirements into sixteen species of dermatophytes.[20]  
In her review Ajello, described the species in Epidermophyton as two, 
Microsporum as 16 and Trichophyton as 21. C.W.Dode, 1935 published the 
association of locally endemic dermatophytes with a particular population 
groups. He also detailed about the immunology, pathology and distribution of 
fungal diseases. 
Weitzman et al restudied the teleomorph state of all dermatophytes 
with sexual phase.  Ajello, Dawson and Gentles, in 1959 discovered the 
teleomorphs of Trichophyton using hair bait technique of 
Vanbreuseghan(1952)[21].Griffin and Stockdale in 1960s independently 
obtained teleomorphs of Microsporum gypseum complex, there by proved 
Nannizzia’s original observation of the sexual stage. [20] 
Williams in 1958 described the first cure in human patient with 
griseofulvin.In 1969, Taplin and co-workers developed DTM to isolate and 
differentiate dermatophyte from other fungal and bacterial contaminant in 
cutaneous lesions. [22] 
Blank and co-workers established the dosage and treatment schedules 
which were widely accepted as the treatment of choice for all forms of 
dermatophytoses.Several topical preparation have also been introduced of 
which tolnaftate has gained wide popularity.  
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More recently imidazoles-clotrimazole, ketoconazole, miconazole and 
econazole have been used as topical agents. Treatment failures and relapses 
occur with all the presently available antifungal drugs. Hence there is a need 
for better therapeutic agents. 
MYCOLOGY 
Most of the fungal infections of the skin, hair and nail are caused by 
dermatophytes, Candida and Pityriasis versicolor .Other less frequent 
infections of skin and hair include tinea nigra and piedra.In addition there are 
number of non dermatophyte moulds that can cause nail infections 
(onychomycosis). 
Superficial fungal infections, such as dermatophytosis and 
onychomycosis have an important problem in diabetic patients due to 
immunosuppression [23]. 
ETIOLOGY 
The organism that cause dermatophytosis (keratinolytic fungi) are 
moulds belonging to the genera Trichophyton, Microsporum and 
Epidermophyton.[23] . They all belong to the, 
Family-Arthrodermataceae 
Order-Onygenales 
Class-Plectomycetes 
Phylum-Ascomycota  
 8
The dermatophytes are hyaline septate moulds with more than hundred 
species. Forty species are considered valid and less than half of these are 
associated with human diseases. These are divided into three main 
anamorphic genera depending on their morphological characteristics [20] as, 
Trichophyton 24 species 
Microsporum 16 species 
Epidermophyton 2 species. 
The two perfect genera corresponded closely to the imperfect genera 
ie, all Microsporum species with perfect stages belong to the genus Nannizzia 
and all Trichophyton species to the genus Arthroderma. 
      Antigenically and physiologically,the dermatophytes are closely 
related but few species shows nutritional differences which have been useful 
in separating similar species.[19] 
The Trichophyton species usually infects skin, hair and nails. 
Microsporum species infect skin, hair and not the nails and Epidermophyton 
species infect skin as well as nails but not the hair[20](Sherne et al 1993). 
These group of organisms are homogenous not only in appearance but 
also in physiology, taxonomy, antigenicity, growth requirements and 
infectivity. The ability of these microorganisms to invade and parasitize the 
cornified tissues are closely associated and is dependent upon the utilization 
of keratin which is a highly insoluble scleroprotein [19] 
ECOLOGY 
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The dermatophytes can be classified into three ecologic groups 
depending on their habitat (natural reservoir) as, 
Geophilic species- Soil 
Zoophilic species- Animals 
Anthropophilic species- Humans  
ANTHROPOPHILC SPECIES 
Anthropophilic species, most commonly causes human infection and 
has evolved from zoophilic species.[21,22].These are highly contagious since 
the arthroconidia and  chlamydoconidia shed in the environment ,along with 
the desquamated epithelium and hairs  can survive longer (Mc Pherson 1957, 
Kwong Chung 1992).[21]. 
Fomites also play a role and infection can be acquired through  
aerosolisation of arthroconidia into the air,e.g M.audouinii –Ectothrix tinea 
capitis and T.tonsurans –Endothrix tinea capitis in children (Houchins and 
Pugliase 1991) and in adults ,tinea corporis,tinea manuum ,tinea unguium 
(Summerbell ,Weitzman 1995). 
T.tonsurans can cause nosocomial infection through aerosolisation. [21]. 
T.rubrum,T.mentagrophytes and E.floccosum can cause tinea cruris,tinea 
pedis and tinea unguium but varies with the geographical locations 
Other anthropophilic dermatophyte species like T.violaceum and 
T.schoenleinii can also be transmitted via fomites (Kwong Chung 
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1992).T.concentricum can be transmitted after birth to the neonate from the 
mother either directly (Rippon 1988) or through fomites.(De vroey 1985)[21]. 
Tinea pedis is acquired by direct exposure to the fungal spores 
commonly seen in shower heads, swimming pool and locker rooms (Gentles 
1957). Epidemiological evidence as analysed by Gentles et al (1957) lstrongly 
documented a 3-fold increase in the incidence of tinea pedis cases among coal 
miners using the  communal showers [21]. 
 GEOPHILIC SPECIES 
The soil contains many keratinophilic fungi closely related to the 
dermatophyte genera and are secondarily transmitted by animals to human 
[21,22]. These includes M.gypseum, M.fulvum, T.ajelloi and T.terrestre.Most of 
these organism are rarely isolated from human infections.  
ZOOPHILIC SPECIES 
Zoophilc species evolved from geophilic species and can cause human 
infections [21,22] Infection caused by the zoophilic dermatophyte,M.canis can 
involve the domestic animals as the principal carriers (,DeVroey 1985, 
McGinnis 1985, Kwong-Chung 1992). 
T.verrucosum and T.mentagrophytes var.mentagrophytes are mostly 
acquired from cattle.In Tinea corporis, tinea capitis and tinea barbae ,fomites 
play a role in the transmission of T.mentagrophytes var quinckeanum (Georg 
1960). T.mentogrophytes var mentogrophytes (granular variety) is carried by 
rodents and can transmit to laboratory workers (Georg 1960,Sewell 1995).[21] 
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Infections acquired from zoophilic species are inflammatory hence 
resolve spontaneously than infection caused by anthropophilic species which 
are non-inflammatory (Rippon1988,KwongChung 1992)[21]. Other zoophilic 
agents are M.gallinae,T.equinum and M.nanum. 
EPIDEMIOLOGY:[21P223-33] 
Dermatophytes affect 20-25% of the world’s population and the 
incidence continues to rise [24, 25]. The distribution of superficial mycoses 
varies among countries. Hence investigators are keen in identifying the 
etiology, distribution, pathology and the treatment strategy, 
Dermatophytes survive at 25-280C .Hence in tropical countries, the 
humid warm conditions on human skin supports its growth. [26]. 
Dermatophytes are geographically restricted and endemic only in particular 
parts of the world [19].   
Skorepova underlined that the frequency of skin mycoses in diabetes 
mellitus is not significantly higher than that in general population. But 
Garcia-Humbria et al demonstrated prevalence of superficial mycoses as 75% 
in diabetes in contrast to 65% in non-diabetic healthy individuals. [27] 
In Indians, occlusion of the infected sites appears to increase the 
susceptibility to chronic infection by increasing the hydration and the 
emission of CO2 which favours the growth of dermatophytes (King et al1978). 
Within a country, the anthropophilic and zoophilic species are not static and  
can change as  a result of population shifts [21]. 
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In North India anthropophilic species are the commonest pathogens 
causing   tinea capitis. In a study on 153 consecutive patients with tinea 
capitis,90% of the patients were aged less than 15years; and the causative 
strains were.T.violaceum (38%),M.audouinii (34%),T.schoenleinii (10%) and 
T.tonsurans (10%).[26] 
In South India, T.violaceum is the common strain causing tinea capitis 
.A study in 1978, proved the occurrence of tinea capitis among boys aged 10-
17years due to the unhygienic mass scalp shaving rituals [26]. 
The commonest causative agents of tinea pedis are T.rubrum and 
T.mentagrophytes and E.floccosum. 
Immunosuppressive states especially diabetes mellitus and oldage, are 
predisposed to chronic infections [12,28]. An inherited pattern of infection with 
T.concentricum is also noted (Serjeantson and Lawrence 1977).[21] 
AGE DISTRIBUTION 
Scalp infections are common in children but can rarely occur after 
puberty. But this infection causes scarring alopecia in adults. The reason for 
the preponderance of the disease in children is due to the presence of medium 
chain fatty acids in sebum which inhibits the growth of dermatophytes in post 
pubertal individuals.[29] 
In constrast, tinea pedis is usually seen in adolescents or young adults. 
Foot infection occasionally occur in young children,but with concomitant skin 
infection.[29]. The prevalence of onychomycosis with tinea pedis is seen more 
among diabetic patients [7].  
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Many of the 40 species are distributed world-wide but the remaining 
strains are confined to specific regions. Hence the study on their ecology and 
epidemiology are essential to control the infections. [21]. 
IMMUNOLOGY:[21]  
Dermatophyes initially colonize the stratum corneum. The infection 
and the inflammatory reaction depend on the causative species and the host 
immunity. Infections with anthropophilic species elicits less inflammatory 
response when compared to  zoophilic and geophilic species 
HOST RESPONSE 
 Innate immunity (Nonspecific)  
 Acquired immunity (Specific) 
INNATE IMMUNITY 
The epidermis and nails synthesize a natural peptide which possess 
antimycotic activities. These peptides are glycated in uncontrolled diabetic 
patients hence they lose their protective function.[30].  . 
Dermatophyte antigens act as chemokines for the leukocytes in 
inflammatory lesions. These neutrophils kill the pathogen through the 
oxidative pathway. It also activates the alternate complement pathway.[29]. In 
diabetes mellitus,due to the glycation of C3 the attachment to the surface of 
microorganisms is inhibited[27]. 
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In diabetic patients, leucocyte chemotaxis, adherence and phagocytosis 
are impaired during hyperglycaemia and are prone for chronic 
dermatophytoses.[17,27]. 
ACQUIRED IMMUNITY 
HMI 
The humoral immune response does not appear to help in the 
elimination of infection and the highest levels of antibodies are often found in 
patients with chronic dermatophytosis.Nonspecific antibodies are produced 
which cross react with other dermatophytes and saprophytic fungi. 
IgE suppresses the CMI through its histamine secretion and HMI is 
variable during dermatophytosis.There is no standard antigen available to test 
its sensitivity and specificity.Matsumoto et al1996). 
CMI 
CMI is by type IV delayed hypersensitivity reaction mediated by 
cellular immune system which  is important in eliminating the infection from 
stratum corneum,[31] and thus results in both mycological and clinical cure 
.(Dahl 1993). 
Trichophytin skin test is positive in normal population because of their 
earlier exposure to dermatophytoses or by cross reactivity to other organisms. 
(Grossman et al 1975) [20]. 
Defective T-cell mediated response causes chronic infection with 
T.rubrum and T.concentricum.Persistent dermatophytic infection elicits Th2 
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immune response.[29] Moreover cutaneous T cell function and response to 
antigen challenge are depressed in diabetic patients. 
The dermatophyte species vary among themselves in eliciting immune 
response,like T.rubrum causes chronic or relapsing infection while 
T.verrucosum causes long term resistance to re-infection.[29] 
PATHOGENESIS 
Dermatophytes colonize and adapt to grow in the living keratinised 
layer of stratum corneum ,in the nail plate ,nail bed and around hair shafts and 
thereby develops equilibrium with the host . They produce only less irritation 
to the specific host.  
Dermatophytes slowly develop specialised methods of reproduction 
and easily disseminates from host to host, by the formation of arthroconidia. 
[32, 33]. These arthrospores are the vegetative cells with thick cell wall which 
transfers the infecting agents from the original specific hosts. [33]. 
The acquisition of infection depends upon the skin surface factors like 
local CO2 tension, moisture and unsaturated transferrin. For penetration it  
needs, zinc containing metalloproteinase.[33] The ratio of epidermis to serum 
glucose concentration is higher in patients with diabetes mellitus which may 
favour fungal growth.[27] 
Human genetics also play a role in the pathogenicity. Autosomnal 
dominant trait is seen in some families with onychomycosis and autosomnal 
recessive trait is seen in tinea imbricata.[34] 
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Several host mediated factors can also limit dermatophytoses, like 
Progesterone (Heoprich et al 1994) hence there is an increased incidence of 
some dermatophytoses in men .Unsaturated fatty acid in sebum  also can 
inhibit the growth of dermatophytes. Thus the production of sebum in adult 
scalp protects against tinea capitis.[34]   
The granular form of T.mentagrophytes var.mentagrophytes, a zoonotic 
infection when infects man, evokes a primary irritant reaction followed by 
severe inflammatory response which leads to rapid termination of  infection.  
Moreover these fungal infections of hair produce numerous saprophytic 
conidia in cultures. On the other hand the anthropophilic species, 
T.mentagrophytes var.interdigitale elicits only little inflammatory reaction 
and causes chronic infections and also produces only few saprophytic conidia 
in cultures.[19] 
On glabrous skin, dermatophytes produce the classical ring worm 
pattern with centrifugal spreading. Most of the dematophytosis resolve 
apparently but some may persists as carriers.[20].  
VIRULENCE FACTOR:[19,21,22,35,36] 
 Dermatophytes produce a number of keratinolytic proteinases that 
function best at acidic pH and these have been recognized as an 
important virulence factors.[37]. 
 The molecular structure of keratin varies from species to species, 
hence different keratinases have been evolved with relative specificity. 
[19]. 
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 Another factor which enhance the pathogenicity is the mannan 
produced by its cell wall (Blak et al, 1991) [34] .which suppresses the 
CMI. 
 Dermatophytes produce catalase enzyme. 
 Dermatophyte also produce enzymes like chitinase or proteinase to 
derive nutrition from the epidermal structures. 
 
CHRONIC DERMATOPHYTIC INFECTION:[21,35] 
Some of the patients are prone for chronic or recurrent infection due to 
the following reasons, 
 Skin provides an environment favourable for fungal growth and 
persistence. 
 Immunosuppression (diabetes) is another cause of increased 
vulnerability to fungal infection. 
 Atopic or those who lack CMI to certain dermatophytes. 
 Recurrence due to under treatment or short term therapy. 
 Resistant to antifungal drugs. 
CLINICAL FEATURES 
 The clinical feature is a combination of direct tissue damage and the 
host immunity. Infection is also enhanced in damaged skin like macerated 
skin as seen in tinea cruris and tinea pedis.[34]. 
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Clinical signs vary with the host and species of the mould. The lesion 
is localised in a circular pattern with features of erythema, scaling and 
pruritis. It spread outwards with healing at the center. [38] 
TINEA CAPITIS 
It is common among children. Anthropophilic species causes endemic 
infections and zoophilic sporadic [29]. It can be caused by sharing of 
contaminated comb, clothing [37]. The predominant cause of tinea capitis is 
Trichophyton species particularly T.tonsurans. 
Anthropophilic species are the predominant agents in 
India.T.violaceum and M.audouinii are the causative agents in North India and 
T.violaceum in South India[24] 
Scaling may be present on the scalp with minimal Inflammation but 
marked with M.canis. Hairs infected with these agents fluoresce green when 
exposed to Wood’s lamp. [33].Clinically classified as,[26]. 
 Non inflammatory- M.audouinii,M.ferrugineum 
 Inflammatory-M.canis,M.gypseum 
 Black dot type- T.violaceum, T.tonsurans 
 Trichophyton species may cause Ectothrix or Endothrix infections. 
 In endothrix infections,hyphae form arthrospores within hair shaft and 
in ectothrix outside the hair shaft.[29].  
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Trichophyton infection of scalp ranges from scaling folliculitis to 
kerion formation. T.mentagrophytes and T.tonsurans commonly cause kerion. 
T.schoenleinii infection causes pustular follicles called as favus which forms  
crust and scutula along the hair shaft. 
Mankodi and Kanvindae (1969) showed that tinea capitis accounts for 
10% of all dermatophytosis. The age group being below 13yrs with male 
predominance and 75% of the isolates were T.violaceum [39]. 
Kamalam and Thambiah (1979) when studied the prevalence of tinea 
capitis  in two schools found ,inflammatory lesion in one school children 
caused by T.violaceum(6.2%) and non-inflammatory lesion in the second 
school children but T.violeceum was isolated in 59.75% cases.Hence 
concluded that the clinical response depends on the species  rather than the  
host immunity [40] 
TINEA BARBAE 
T.verrucosum and T.mentagrophytes var.mentagrophytes were the 
principal causative agents. The characteristic appearance is of a localised, 
highly inflammatory pustular follicules. Some infections are less severe with 
circular, erythematous, scaly lesions [33] 
TINEA FACIEI 
The causative species are T.rubrum and T.mentagrophytes var 
mentagrophytes , T.tonsurans and M.canis. The typical annular lesions are 
erythematous pruritic,but scaling is often absent. The lesions are often 
exacerbated by sun exposure [29]. 
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TINEA CORPORIS 
It is the most common infection [39, 41].The clinical features depend on 
the species of the infective organism. The disease often follows contact with 
infected animals, but occasional cases are with geophilic species (M.canis and 
T. verrucosum). 
Infections with anthropophilic species can be secondary from tinea 
pedis and are commonly seen as  a nodule on the lower part of the legs with 
the overlying skin appearing dry,red and scaly.[29] 
The characteristic lesion is an annular scaly plaque with a raised 
erythematous border and central clearing. In their most florid form, the 
lesions can become indurated and pustular which is very common with 
zoophilic species. Sites commonly involved are the trunk and legs.  
Mankodi and Kanvindae (1969) found that tinea corporis was the 
commomest dermatophytosis (52,8%) in Ahamedabad and in Bombay (54%) 
by Mehta Deodhar chaphekar (1977). 
TINEA CRURIS: 
Infection of the groin and the perianal region.Perineal regions is more 
often affected in men. The predominant causes are the anthropophilic species 
,Trichophyton rubrum and Epidermophyton floccosum. The infection can be 
from other sites but person to person spread is also not uncommon. 
The lesions are erythematous and have raised scaly margins which 
radiate from the groin down the inner border of the thigh. Patients often 
complaints of intense pruritis [33] 
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Panda, Mohanty and Nanda (1967) from Burla reported the commonest 
dermatophytoses as tinea cruris accounting for 54.65% with 98.5% cases 
noted in males and the commonest isolate was T.rubrum(78.4%).  
TINEA IMBRICATA 
A variant of tinea corporis caused by T. concentricum.This is a chronic 
infection characterised by the development of homogenous sheets or 
concentric rings of scalings that can spread to cover a large parts of the 
affected person.[33]   
TINEA PEDIS 
Infection of the feet is most often seen in diabetic patients.Casautive 
agents being T.rubrum,T.mentagrophytes var interdigitale and E.floccosum.  
The most common clinical presentation is interdigital or web space infections 
which commonly involves between the fourth and fifth toes. 
Another common feature associated with T.rubrum infection is the 
hyperkeratosis of the sole, which is presented as dry ,white scaly lesions. This 
form of the disease is often chronic and resistant to treatment. If there is 
extensive involvement of the foot, then the term ‘moccasin ‘or dry type  tinea 
pedis’is often applied. 
A third form of tinea pedis, associated with T.mentagrophytes 
var.interdigitale,is the vesicular lesion involving the soles. This acute lesions 
usually resolves spontaneously. Sometimes exacerbations tend to occur under 
hot humid conditions. This condition is often associated with hyperhidrosis 
[33] 
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Desai and Bhat (1961) reported a higher incidence of tinea pedis 
among those wear shoes and socks.Baer and Rosenthal (1966) in their 
experimental study found that trauma played a contributory role. 
TINEA MANUUM 
It is usually unilateral. Lesions appearing on the dorsal side shows 
similar appearance to tinea corporis, with distinct border and central clearing. 
Infection of the palms is more common. This presents as a diffuse scaling 
hyperkeratosis, with accentuation of the fissuring in the palmar 
creases.T.rubrum is the most common etiological agent. 
TINEA UNGUIUM: (ONYCHOMYCOSIS) 
Onychomycosis,the fungal infection of nail is the commonest 
superficial mycosis seen among diabetic patients. Atleast 80% of fungal nail 
infections are caused by T.rubrum and T.mentagrophytes.[27,42].Saunte et al 
revealed 93% of onychomycosis were due to dermatophytes.[27] 
The various clinical forms of tinea unguium are, 
 Distal and lateral subungual onychomycosis (DLSO) 
 White superficial onychomycosis (WSO) 
 Proximal subungual onychomycosis (PSO) 
 Total dystrophic onychomycosis (TDO) 
DLSO is the commonest type. This usually begins as a discoloration 
and thickening of the distal and lateral borders of the nail. Finally it  results in 
destruction of the entire nail plate and separation of the nail from the nail bed.  
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White superficial onychomycosis is common in toe nails and causes 
white crumbling  lesions  involving only the nail surface.This condition is 
most commonly caused by T.mentagrophytes Var.interdigitale. 
Proximal subungual disease is a rare presentation involving the finger 
nails.The nail appears as whitish yellow with periungual inflammation.In total 
dystrophic onychomycosis, there is complete loss of nail plate. 
Onychomycosis or tinea pedis in a diabetic patient should be monitored 
and treated earlier, as it can disrupt the skin integrity .In untreated cases, 
these can act as a reservoir and can further favours secondary bacterial 
infections. 
Ravinder Kaur et al (2008) in clinicomycological evaluation of 
onychomycosis isolated T.rubrum (46.67%),T.mentagrophytes (20%) 
,T.tonsurans(4%) and reported that the infection was  more common in males 
in the age groups of 21-30  and 61-70 years. [42] 
Dermatophytoses in toe web space leads to inflammation and fissuring. 
In diabetic patients these fissures can result in serious complications like 
paronychia and also act as a portal of entry for bacteria. 
LAB DIAGNOSIS 
The diagnosis of dermatophytosis is based on combination of clinical 
observations supplemented by laboratory investigation. [20] 
COLLECTION OF SPECIMEN 
After decontaminating the affected area, the specimens of infected 
skin, hair and nail are collected in a dry sterile container. [43] 
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The laboratory diagnosis depends on [20] 
 Demonstration of the causative pathogen in tissue by microscopy. 
 Isolation of fungus in culture 
 Serological tests. 
DIRECT MICROSCOPY 
It is not a sensitive test for detecting dermatophytoses but it is more 
rapid, simple method of determining the etiology of an infection when the test 
is positive [20,43]. Moreover it is helpful in determining whether the organism 
recovered later in culture is a contaminant or a pathogen and also to select 
further specific culture medias and tests.[34] 
The clinical material should be examined by suspending a portion of 
the sample in a clearing agent, KOH -10% used for skin and hair but 20%  for 
nails. 
In KOH mount, the fungus is seen as branching hyaline mycelia,which 
frequently show arthrospore production. The demonstration of fungus in nails 
may be difficult and may be possible only after keeping clippings in KOH for  
overnight. For all types of clinical specimens, fungal hyphae must be 
differentiated from other artefacts. [20] 
MODIFICATION OF KOH MOUNT:[21P235] 
 KOH with dyes or blue black ink 
 Addition of DMSO (36%) to KOH (20%). Others being 
dimethylacetamide and dimethylformamide. 
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 Glycerine (5-10%) to 10-25% KOH. 
 10% Sodium disulphide solution. 
OTHER SPECIAL STAINS 
 Calcoflour white stain 
 Periodic acid Schiff stain (PAS) 
 Gomori’s methenamine silver stain (GMS) 
 Immunofluorescence stain 
CULTURE 
The clinical specimen should be inoculated on fungal culture media 
irrespective of their findings in direct microscopic examination [20]. 
Cultures of dermatophytes require media containing antibiotics. 
Because specimen from cutaneous sites almost always contain the normal 
bacterial flora of the skin, hair and nails in addition to saprophytic fungi from 
the environment. 
 
MEDIA 
 Emmon’s modified SDA with antibacterial agents such as 
chloramphenicol and or gentamicin and cycloheximide to reduce 
growth of saprophytic fungi.  
 SDA with chloramphenicol should always be included in any regimen 
for culture.[43] 
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The inoculated cultures are incubated at 250 C, 300 C and 370 C.  The 
growth is relatively slow and takes 10 days to three weeks.[20] T.verrucosum 
and some strains of T.tonsurans grow only at 370 C. 
At the onset of sporulation and pigment production growth is examined 
by LPCB mount.The cultures are examined three times weekly for four weeks 
and appropriately sub cultured onto SDA. 
DERMATOPHYTE TEST MEDIUM: [REBELL&TAPLIN 
1974] 
DTM is used for presumptive identification of dermatophytes [43]. All 
samples of dermatomycosis can also be inoculated onto the DTM and 
incubated at 250C.This selective primary medium is helpful in isolating 
pathogenic species from cutaneous specimen. Thus DTM can be used to 
isolate and distinguish dermatophytes from the saprophytic fungus. 
 
PRINCIPLE 
Dermatophytes utilize the proteins present in the medium and turns the 
medium red by raising the pH (alkaline metabolite) indicating their presence, 
while most other fungi and bacteria utilizes the carbohydrate in the medium 
and hence no color change or pH occurrs.  
PROCEDURE 
The sample should be inoculated onto the agar as soon as possible with 
a sterile forceps and is incubated at 22-250C for upto 14 days.The culture 
should be examined daily for change in color of the medium and evidence of 
fungal growth for 7-10days and later discarded. 
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INTERPRETATION 
 Red color media with white cotton like growth.-Presumptive 
identification of dermatophytes. 
 Yellow color media with no growth - No dermatophyte in the 
sample. 
 No color change in the medium with white/off white creamy 
growth-C.albicans. 
DISADVANTAGE [21 pg236] 
Pigment production cannot be appreciated.It is only a screening media 
and not a specific media for dermatophytes since non pathogenic species can 
also change the color on prolonged incubation. 
OTHER MEDIA [43] 
 DIM-Dermatophyte identification medium 
 SDA with yeast extract. 
 PDA-potato dextrose agar        pigmentation are better seen and to  
 PFA-potato flake agar              enhance sporulation  
 Corn meal agar 
 Trichophyton agars (1-7) 
 Inhibitory mould agar 
 Littman oxgall agar with antibiotics (Summerbell et al1989) 
 Casamino acid/Erythritol/Albumin 
 BCP/Casein yeast extract. 
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COLONY MORPHOLOGY [43] 
Colonies with one pigment on the surface of the colony and another 
pigment other than black on the reverse are likely to be dermatophytes. 
[43]The dermatophyte isolate can be distinguished from contaminant by their 
compact growth around the inoculum and by the color of colony.[20] 
IDENTIFICATION OF DERMATOPHYTES [43] 
Trichophyton species:[Malmsten1845] Macroconidia are sparse (8-
86x4-14µm) or absent. 
1)T.mentagrophytes: 
Macroscopy: T.mentagrohytes-type-I colony (zoophilic) are 
flat,granular,creamy with yellow to tan or reddish brown reverse. 
T.mentagrohytes-type-II colony (anthropophilic) are flat and downy 
with surface pigment cream to light yellow with white feathery fringes and 
light yellow reverse. 
Microscopy 
Type-I: Macroconidia are abundant which are clavate to cigar 
shape,smooth walled with 3-6cells. Microconidia is also abundant which are 
globose and unicellular ( en thryses) or in clusters (en grappe). 
Type-II: Macroconidia are sparse or absent.Microconidia also are 
sparse which are clavate or pyriform.Nodular hyphae are frequently seen.Both 
types show branching conidiophores at right angles, arthroconidia  
chlamydoconidia and spiral hyphae.  
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2)T.rubrum: 
Macroscopy: 
Type-I: White downy to fluffy colony.The reverse is yellow to blood red 
Type-II: Surface pigment becomes tan,yellow or tinged with red and 
texture is granular. The reverse pigment may be colorless, tan or yellow to 
brown but eventually a deep wine red color. 
Microscopy: 
Type-I:macroconidia are sparse or absent but abundant in type-II 
colony.These are narrow,cylindrical with blunt distal ends and thin smooth 
parallel walls showing 3-8 cells. 
Microconidia are also abundant in type-II colonies and are clavate or 
tear drop forms arranged singly or occasionally in clusters. Chlamydoconidia, 
nodular bodies, pectinate hyphae and racquet hyphae are also seen. 
T.tonsurans [44] 
Macroscopy: Powdery, heaped with yellow surface. 
Microscopy: Abundant microconidia but rare macroconidia. 
T.verruccosum  [44] 
Macroscopy: White waxy heaped growth at 370C 
Microconidia: Plenty of chlamydoconidia with absent macroconidia. 
T.Violaceum[32] 
Macroscopy: Slow growing violet or deep port wine colour colony 
with a yeast like consistency . 
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Microscopy: Distorted microconidia 
Microsporum species: [Gruby 1843] 
Macroscopy: The colonies are cottony,velvety or powdery with white 
to brown pigmentation in M.gypseum and yellow orange pigment in M.canis. 
Microscopy: 
Macroconidia are abundant (6-160x6-25µm) which are large,rough 
walled,multicellular,spindle shaped.M.canis forms numerous thick walled,8-
15 celled with hooked spiny tip.In M.gypseum ,it is boat shaped with 4-6 
cell.M.audouinii produces only thick walled chlamydoconidia. 
Microconidia are scanty. 
Epidermophyton species [Sabouraud1907] 
Macroscopy: Slow growing,powdery,greenish brown with suede like 
surface. 
Microscopy: Macroconidia are smooth (20-60x4-16µm) thin, pear or 
club shaped with 1-9cells.Microconidia are not produced. 
MICROSCOPIC METHODS  
Tease mount(LPCB) 
Cultures are examined microscopically by examining a portion of the 
aerial mycelium. The material is placed on a slide in a drop of LPCB.The 
matted  mycelium is gently teased with a pair of teasing needle. A coverslip is 
placed and the morphology observed under microscope. 
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Slide culture 
In a petridish with V shaped glass rod, a glass slide ,a coverslip were 
placed and sterilised in hot air oven 1x2 cm SDA block is placed on the slide 
and the corners are inoculated with the fungal colony.The whole set is 
incubated at Room Temperature after adding distilled water 
Cellophane/Scotch tape preparation:[45pg91] 
A 2inch piece of cellophane tape is taken and the sticky side is 
carefully placed on the colony. The speculating colony stick on to it and then 
the tape is gently placed with the sticky side down on a slide with LPCB. 
All preparations are examined for the presence of hyphae, 
microconidia, macroconidia,, their size, shape and arrangement and other non-
reproductive vegetative hyphae (spiral hyphae, racquet hyphae, nodular 
hyphae). 
PHYSIOLOGICAL PARAMETERS 
To identify and speciate the isolates which may show similar 
morphology especially Trichophyton species,Physiological tests are 
performed.[45 pg237] They includes, 
Nutritional requirement:[21] 
Trichophyton agar (1-7) is used to differentiate the Trichophyton 
species, 
Temperature: 
Most dermatophytes grow at 25-300 C.T.verrucosum grows only at 
370C. 
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Pigment production: 
Most of the T.rubrum produces cherry red colour under the colony but 
to differentiate slow pigment producing variants of T.rubrum from 
T.mentagrophytes, PDA and CMA are used to induce pigment production. 
Urease production [46] 
T.mentagrophytes produces urease and T.rubrum does not,Hence to 
differentiate it Christensen’s urease medium is used(Philpot1967,Clayton & 
midgley1989).Other urease producing Trichophytons are T.megninii , 
T.raubitschekii.(variant of T.rubrum) and urease negative species is 
T.erinacei..[21] 
Invitro hair perforation test  [46,45pg237] 
T.mentagrophytes and M.canis can perforate normal human hair (<5yrs 
of age) producing wedge shaped tunnels or holes.T.rubrum and M.equinum do 
not perforate and thus can be differentiated. 
Rice grain test [20] 
Except for M.audouinii,all other microsporum species grow rapidly on 
sterile rice grains 
Hair bait technique 
This is performed to isolate geophilic dermatophytes from soil like 
M.gypseum. 
SEROLOGY [20] 
The skin test with trichophytin, which is a crude extract produces 
delayed type hypersensitivity reaction in most adults.The carbohydrate 
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portion is related to an immediate response whereas the peptide moiety to 
immunity.Absence of these reaction leads to chronic dermatophytoses. 
Immunodiffussion test are done for the diagnosis of 
dermatophytoses.[20] 
ANIMAL INOCULATION [20] 
Animal pathogenicity testing is done on laboratory animals like guinea 
pig, mice and rabbit .Animals can be infected with geophilic and zoophilic 
dermatophytes. The area to be inoculated with conidia and hyphae is shaved 
and scarified. The isolates are inoculated and growth is seen in 7days. The 
lesion usually resolves by 3-4weeks in most of the cases. 
MOLECULAR TECHNIQUES: To assess the relatedness and 
taxonomic classification of the dermatophytes, Mitochondrial DNA analysis 
of dermatophytes using BG II; HaeIII and PCR are being done 
ANTIFUNGAL SUSCPTIBILITY TESTING 
Antifungal susceptibility testing has received much attention with the 
advent of newer antifungal drugs. But it is not advanced as with bacteriology. 
It must provide a reliable measure of the relative activity and also correlate 
with in vivo activity. [47].  
AFST is done to ascertain the minimum inhibitory concentration by 
which the in vivo effectiveness of an antifungal drugs can be assessed. 
Moreover the development of drug resistance can also be determined. [48]. 
AFST depends on the following parameters, 
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 pH of the medium 
 Inoculum size of the isolate 
 Medium 
 Time/Temperature of incubation 
 Invitro-invivo correlation 
METHODS 
 Broth dilution(CLSI M38A)-Macrodilution and Microdilution 
 Agar dilution 
 Disk diffusion 
 E-test 
TREATMENT 
 Antifungal antibiotics 
 Synthetic antifungal drugs 
 Miscellaneous drugs. 
ANTIFUNGAL ANTIBIOTICS 
Griseofulvin is a narrow spectrum antibiotic produced by Penicillium 
griseofulvum and Khuskia oryzae. It inhibits mitosis by interfering with 
polymerised microtubule and spindle formation.It is fungistatic agent. 
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SYNTHETIC ANTIFUNGAL DRUGS 
 Thiocarbamate: Topical agents-Tolnaftate 
Allyiamine and benzylamine: Selectively inhibits squalene epoxidase 
which is needed for fungal ergosterol synthesis. Hence it is fungicidal. 
Azoles: It inhibits cytochrome P450 dependent C14 demethylation in 
ergosterol synthesis. This causes accumulation of abnormal sterols and 
ultimately fungal death. 
      Imidazole 
 Triazoles: 
MISCELLANEOUS DRUG 
 Ciclopiroxolamine: Pyridine analogue which inhibits fungal cell wall 
synthesis and also inhibit metal dependent enzyme.used as 1% cream. 
 Whitfield’s ointment: It is a mixture ofbenzoic acid (fungistatic) and 
salicylic acid(keratolytic) in the ratioof 2:1.it is used for tinea pedis. 
 Castellani paint-1.5% carbol fuschin. 
 Undecylenic acid: it is used as soap and foam for tinea pedis. 
 Haloprogin:used as 1% cream 
 Triacetin:used as 25% cream with cetylpyridinium and chloroxylenol. 
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PREVENTION [21] 
Prevention and control depends on the site of lesion,causative species 
and its source . For scalp infections,all the contacts are screened by wood’s 
lamp examination for fluorescent hair (Microsporum species) including pet 
animals. In case of non-fluorescent tinea capitis (T.tonsurans, T.violaceum), 
the scalp is carefully examined for the presence of spotty alopecia and scaly 
lesions. The suspected lesion should be cultured regularly. 
Tinea corporis and tinea cruris can be transmitted with contaminated 
clothing, bedding, towel hence washed and disinfected regularly. Avoidance 
of use of tight fitting, non absorbent cloth and prolonged exposure to wet 
cloth and weight reduction can prevent the occurrence of tinea cruris.[34pg374] 
To prevent the occurrence of tinea pedis /onychomycosis, protective 
footwear can be worn when using public facilities. To prevent recurrence, 
measures should be taken to reduce foot moisture, like drying foot after baths 
and applying antifungal powder.Richardson, Elewski (2000) et al has stated 
that treatment of tinea pedis can prevent tinea manuum.[34] 
For zoophilic infections, the source must be traced and treated. 
Summerbell and Weitzman (1995) detailed the preventive measures like good 
sanitation and use of fungicidal sprays. 
VACCINE 
A live vaccine (LTF130) against T.verrucosum was introduced for 
cattles in the former Soviet union (Segal 1989) [21]. 
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CANDIDA 
HISTORY 
Hippocrates Epidemics described the candidial infection and 
candidiasis in two patients in the fourth century B.C.The French word for this 
condition was ‘Le Muguet’ meaning ‘lilly of the valley’. The first case of oral 
thrush in modern medicine were made by Rosen von Rosenstein (1771) and 
later by Underwood (1784) 
Candida albicans were variedly named as Oddium albicans (Robin-
1853); Syringospora robinii(Quinquad-1868);Saccharomyces albicans(Reess-
1875). Grawitz (1877) published the various morphological forms of candida 
albicans 
Zopf in 1890 named the fungus Monilia albicans.Dubendorfer (1904) 
described onychomycosis.Aldo castellani (1912) was the first to suggest the 
possibility of candida species other than albicans, namely C.krusei and 
C.tropicalis. 
In Eighth botanical congress (1954) the generic name Candida was 
finally accepted. In 1978 Torulopsis was merged into the candida genus and 
named as C.glabrata. Research towards Candida species were started actively 
after the advent of antibacterial agents and their indiscriminate usage and also 
the emergence of AIDS pandemic. 
MYCOLOGY 
Candida albicans was considered to be the commonest species but 
frequency of non albicans candida is on the rise.[33] In Candida species there 
are 163 anamorphic species with telomorphs in 13 genera.[20] 
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PHYLUM-Fungi imperfecti 
ORDER-Moniliales 
FAMILY –Cryptococcaceae. 
Candida posses β glucans in their cell wall and do not produce starch 
or carotenoid pigments.Serotypes in Candida albicans-A and B based on on 
their difference in mannan component of cell wall. 
STRUCTURE 
Candida is a small (4-6µm), oval, thin walled yeast like fungi which 
reproduces by a process of budding. They produce blastospores and 
pseudohyphae.[34] The cell wall is composed of phosphorylated mannans, 
glucans and smaller amount of chitin on which the polysaccharide and 
proteins are intimately bounded. 
The difference among candida species is in the phospho glycopeptide 
oligomers and polymers. The cell wall contains active protein, enolase,N-
acetyl glucose aminidase,ubiquitin like epitope hsp 70. 
Candida is an eukaryotes with a nucleus containing RNA rich single 
nucleolus and double layered nuclear membrane. The cytoplasmic membrane 
contains ergosterol, Cytoplasm contains mitochondria, vacuoles, vesicles, 
endoplasmic reticulum, microtubules, ribosomes and glycogen crystals but 
Golgi apparatus is absent. 
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   EPIDEMIOLOGY 
Candidiasis has no geographical limitation as it occurs in patients who 
are predisposed to an overgrowth of their endogenous flora.[49].One exception 
is C.viswanathii which is reported only in India(Davis 1986)[21] 
Candida is commonly found on skin, GIT,oropharynx and female 
genital tract.[22].and can be isolated from various sites .There are many factors 
which predispose to superficial and deep seated candidiasis which can alter 
the balance of normal microbial flora of the body or lower the host resistance. 
Candida species causes infections in all age groups but more 
commonly in new borns and elderly people. Other predisposing factors 
includes underlying systemic disease such as diabetes, immunosuppression by 
disease (AIDS) or medication, antibiotic therapy ,IV drug abusers, 
haematological malignancy, indwelling urinary catheters.[50] and disrupted 
epithelial barrier.Warm moist environment favour the growth of candida.[34] 
Apart from Candida albicans which is the common etiological 
organism, there is an increasing incidence of non albicans candida namely 
C.tropicalis, C.krusei, C.glabrata and C.parapsilosis[,20] especially among 
diabetes. In addition, other factors like dimorphic parameter,specific genetic 
susceptibility have also contributed to the increased prevalence of non 
albicans candida. 
Introduction of various anti mycotics and their indiscriminate usage 
has resulted in the selection of specific species that are inherently less 
susceptible to the specific drugs, like C.glabrata and C.krusei intrinsically 
resistant to fluconazole. 
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VIRULENCE FACTOR [51pg423-30] 
 Toxins- glycoprotein extracts of candida cell wall 
 Complement receptors- Candida albicans has the ability to bind 
complement derived opsonins through iC3b. (Calderone and 
Braun1991). As a result they possess the capacity to produce bio films. 
Hence show poor response to antimycotic drugs. [51,34]. 
 Chronic hyperglycaemia induces the expression of C3 and this kind of 
molecular mimicry contributes to easy colonization and infection. [27] 
 Adhesion [21]- Candida adhere to exfoliated human epithelial and 
mucosal cells through its mannan (Douglas 1987) and chitin(Segal and 
Sandovsky-Losica1995,1996). The counterpart on host cell is fucosyl-
glucosamine, fibronectin or arginine-glycine-asparagine (Hostetter 
1994)[47].  GT formation also helps in adhesion. Adhesion is achieved 
through nonspecific (electrostatic charge, van der walls force) and 
specific mechanism (ligand receptor interactions)[52]. Level of 
adherence correlates well with the pathogenicity. (Samaraanayake et al 
1994). 
 Phenotype switching-Morphological colony changes from smooth to 
rough; white to opaque.[53]. Thus it can adapt to various anatomic 
sites,commensalim to pathogenicity and evade immune defence. 
 Yeast-hyphal morphogenetic transformation facilitate penetration and 
also assist in evading the host defence system.[34] (Shephard,Poulter 
andSullivan 1985) 
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 Enzyme production.-secretory aspartyl proteases (SAP)-tissue 
penetration and invasion.[21,34] through degradation of keratin and 
collagen. 
 Phospholipase (ogawa et al 1992) [34] at hyphal tip aids in greater 
invasiveness.Moreover these hyphal form are larger hence easily 
phagocytosed.(Diamond and Krzesicki 1978) 
IMMUNOLOGY [21] 
Both humoral mediated and cell mediated immunity play a vital 
role.CMI play the major role in mucocutaneous candidiasis. Hence 
immunocompromised individual are at increased risk of acquiring superficial 
mycosis.The cells involved are CD4+Th1 cell, which activates macrophages 
which is a candidacidal, through IFN-ɤ, IL, GM-CSF  
Activated immune cells also releases free oxygen radicals and cationic 
proteins which has antifungal effect. Polymorphonuclear cells can 
phagocytose and kill candida species through their primary granular enzyme, 
myeloperoxidase anddefensins (Domer and Carrow 1989;Greenfeld 1992) 
Phagocytosis and killing of candida species are also performed by 
complement, antibodies and cytokines like IFN-ɤ, TNF. Complements act on 
CR2, CR3 present on C.albicans. Hence diverse cells are involved in the 
defence mechanism against candidiasis 
Immunomodulatory effects of fungal determinants reduces the activity 
of host’s defence system.[34] (Cassone 1989,Domer et al 1992)Hyperglycemia 
promotes yeast adhesion and diminishes its phagocytosis[51]  
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PATHOLOGY 
Superficial Candidiasis is an endogenous infection. The shift results 
due to a number of influences,of which host factors appear to be the most 
important.[26] Local tissue damage associated with immunosuppressive state is 
the critical factor in the pathogenesis of cutaneous candidiasis in diabetes[54] 
Candida being normal commensal, the predisposing factors like 
diabetes mellitus can impair the immune response to these organism and this 
imbalance favours mycobiota,which later damages the integrity of the 
integuments. 
CLINICAL FEATURES 
Candidal infection (moniliasis) is an early sign of an undiagnosed 
diabetes.They can present with, intertrigo (axillary,under the breast,groin, 
inguinal, web space), [Hay1999], paronychia, onychomycosis and glossitis.[17] 
 
SUPERFICIAL CANDIDIASIS 
Cutaneous candidiasis is a less common disease causing superficial 
mycosis than dermatophytes [33] This yeast-like fungus presents as an itchy 
rash which are surrounded by tiny blisters.[33] 
Macroscopically these lesions are characterised by the formation of a 
greyish plaque, surrounded by oedema. A special feature of these lesion is the 
formation of warty growth which results from hyperkeratosis and epithelial 
hyperplasia[34] .  
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The lesion is influenced by interaction of three factors, namely the site 
of infection, the pathogenicity of the infecting organism and the competence 
of host immune response.[34] 
Infection of the skin between the fingers or toes can also occur.  It is 
often uncomfortable and may be painful. Infection of webs of the toes mimics 
tinea pedis and many cases do occur in conjunction with this form of 
dermatophytosis. 
WEB SPACE INFECTION (Erosio interdigitalis 
blastmycetica)[34] 
Most common between the third and fourth finger andfourth and fifth 
toe due to trapping of moisture. Clinically the skin appears macerated with 
scaling and fissures. 
NAIL INFECTION 
Less than10% of the infections are due to non dermatophyte organism 
and of which 50% is Candida and it is common in immunocompromised. 
Dogra et al found 48% of nail infection in diabetes were due to yeast like 
fungi.[27] 
a)Paronychia 
Infection of the nail folds is characterised by inflammation and painful, 
erythematous swelling.[42] It is common in woman and in finger nails. 
Causative agent being C.albicans,C.parapsilosis and C.guillermondii. 
Secondary bacterial infection is a serious complication in diabetic patients.[34] 
(Scher,1990).It first attacks the soft tissue around the nail and then invades 
the nail plate.[34] 
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b)Onychia: 
It is the involvement of the finger nail by candida species. The nail is 
discoloured, eroded, brittle and finally detach from the nail bed and is 
painful.[34] 
c)Onychomycosis: 
It causes total dystrophic onychomycosis. Distal nail infection presents 
as onycholysis [Elewski et al1995] and subungual hyperkeratosis. In contrast 
to dermatophytosis, candidiasis affects commonly fingernails.  
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DIAGNOSIS 
 Direct microscopy 
 Isolation in cultures 
 Biochemical identification 
 Phenotypic identification 
 Molecular methods 
DIRECT MICROSCOPY 
Skin scrappings, nail clippings are examined by  
 Wet mount 
 KOH mount, 
 Gram staining 
 Calcoflour white stain 
 Haematoxylin and eosin staining 
 Gomori’s methanamine silver stain 
ISOLATION IN CULTURES 
 SDA with antibiotics                                          
 SDA with antibiotics and cycloheximide 
 Both incubated at incubated at 280 &370 C.Colonies appear in two to 
three days. 
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MORPHOLOGY 
Macroscopy: Smooth,creamy,pasty,glistening colony. 
Microscopy: Globose, or short ovoid cells 
SPECIATION OF CANDIDA 
Chrom Agar 
 It is used for selective isolation and speciation of yeasts  
 Presumptive identification of the candida species. 
This media contains chromogenic substrates. These reacts with the 
enzymes secreted by the yeast and produce colonies of varying colors when 
incubated at 370 C for 48-72hrs. 
OTHER METHODS 
 Corn meal agar and Rice starch agar-for the formation of 
chlamydospores. 
 SDA broth 
 Temperature differential studies 
 Assimilation of sugar 
 Fermentation of sugar 
 α Glucosidase activity 
 Nucleic acid hybridization studies. 
Germ tube test: To differentiate C.albicans from other non  albicans candida. 
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BIOCHEMICAL CHARACTERIZATION 
Sugar assimilation tests: 
It determines the ability of a yeast to utilize a specific sugar as its sole 
source of carbon in the presence of oxygen. 
Sugar fermentation test: 
It is a liquid media supplemented with different carbohydrates .The 
acid production and gas formation are assessed. 
MOLECULAR METHODS: 
 Electrophoretic pattern of DNA 
 RNA profiling 
 Restriction enzyme analysis 
 PCR 
ANTIFUNGAL SUSCEPTIBILITY TESTING 
Broth dilution (CLSIM27A3)-Macrodilution and Microdilution 
 Medium-RPMI1640;pH-7.0 
 Inoculum-1000cells/ml 
 Incubated at 350 C for 48hrs. 
AGAR DILUTION 
 Disk diffusion (CLSIM44A)-fluconazole and voriconazole. 
 E-test 
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COLORIMETRIC METHOD 
 Neosensitab 
 Fungitest 
FLOW CYTOMETERY  
TREATMENT 
Topical preparations 
 1% Gentian violet 
 Nystatin  
 Azoles-cream-ketoconazole,clotrimoxazole,miconazole and econazole 
Oral drugs 
 Ketoconazole 
 Fluconazole 
 Itraconazole 
IMMUNOTHERAPY [45pg267] 
For azole resistant strains, especially non albicans candida,antibody to 
SAP, mannan and mannoprotein had been tried.[walker et al2000,Mathema et 
al 2001,Feris 2002] 
PREVENTION[34] 
Reinfection with superficial candidiasis can be prevented by 
minimising the predisposing condition,by drying the affected areas thoroughly 
to avoid maceration  in susceptible patients. 
 49
VACCINE [21] 
Though various fungal extracts like live,attenuated and killed 
preparations as well as subcellular components were explored,no clinically 
available immunogens of proven efficacy has been obtained. 
NON DERMATOPHYTE MOULDS 
A few NDM, have the ability to invade keratinised tissue and produce 
infection that clinically resemble dermatophytoses. In immunocompromised 
host (DM) it causes 10-15% of onychomycosis,due to Scopulariopsis 
brevicaulis, Scytalidium dimidiatum, Aspergillus spp and Fusarium 
spp.Unlike dermatophytes, these moulds are not contagious and are common 
in toenails. 
Scytalidium dimidiatum and Scytalidium hyalinum can invade skin and 
nails. It is acquired from plants or soil and occur in endemic 
areas.Scytalidium hyalinum is an albino variant that has not been recovered 
from the environment.[34] Scopulariopsis brevicaulis, a soil parasite with 
world-wide distribution and causes onychomycosis by invading damaged or 
traumatised nail.[34] 
Other non dermatophyte moulds includes,Aspergillus flavus, 
Aspergillus fumigatus, [55], Acremonium spp  and Fusarium spp which also 
causes onychomycosis.Aspergillus species causes 2% of onychomycosis and 
which causes proximal subungual paronychia without pus.[56] 
Onychomycosis caused by Fusarium spp and Acremonium species are 
routinely not speciated (McAleer 1981, Velvez and Diaz 1985). But recently 
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it has been speciated as F.solani, F.oxysporum and Ac.strictum in 
immunosuppressed individuals [34]. 
Rhizopus species causes onychomycosis in immunosuppressed patients 
especially diabetes which appear as yellow tan demarcated area of 
discolouration in the nail.It needs total avulsion of the affected nail to clear 
the infection completely.[57]  
PATHOGENESIS 
Non dermatophyte moulds infect keratinised tissues of 
immnunocompetent host and produce keratinases (Hoeprich et al,1994). 
Clinically they resemble anthropophilic dermatophytes.[34] 
LABORATORY DIAGNOSIS 
WET KOH MOUNT 
Hyaline septate hyphae of S.hyalinum resembles dermatophytes. Hence 
culture identification in actidione free media is essential to isolate [34]. 
S.dimidiatum shows phaeoid septate hyphae that can be easily differentiated 
from dermatophytes. 
OTHER NDM 
Malassezia furfur is a common commensal organism that colonise the 
normal skin of the head and trunk during late childhood.[33].It is uncommon in 
diabetic patients [7] 
Tinea nigra is a chronic infection of palms and soles. The etiological 
agent.is Phaeoannellomyces werneckii, which is a saprophytic mould. Human 
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infection is by traumatic inoculation.Black piedra, is an uncommon hair 
infection occurring in tropical regions.  
MANAGEMENT 
Nondermatophyte moulds are difficult to eradicate but itraconazole is 
effective in nail infections caused by Aspergillus spp,Fusarium spp and 
Scopulariopsis brevicaulis with mycological and clinical cure of 88%.[20] 
Topical Amorolfine Lacquer (Downs et al 1999) with oral drugs are effective 
for S.hyalinum. [45pg244] 
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AIMS AND OBJECTIVES 
 To study the prevalence of superficial mycoses in Diabetes Mellitus. 
 To isolate and identify the causative organisms of superficial mycoses . 
 To evaluate the minimum inhibitory concentration (MIC) and the 
antifungal susceptibility pattern of the isolates. 
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MATERIALS AND METHODS 
ETHICAL CONSIDERATION 
The study was conducted after obtaining approval from the 
institutional ethical committee of Madras Medical college, RGGGH, Chennai. 
Permission to conduct this study was received from the Institute of 
Diabetology and Institute of Dermatology .Informed consent was obtained 
from the patients before their enrollment in the study. 
STUDY PERIOD 
One year from October 2011 to September 2012. 
Study setting 
Institute of Microbiology, Madras Medical College, Chennai. 
STUDY DESIGN 
Study group 
All diabetic patients attending diabetology  and dermatology OPD and 
those admitted with fungal infections of skin,hair and nail. 
Sample size-150 
Inclusion criteria 
All diabetic patients (type I and II) presenting with clinical features 
suggestive of superficial mycoses. 
Exclusion criteria 
 Patients on immunosuppressive drugs 
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 Patients on Systemic antibiotic therapy 
 Patients on oral contraceptive pills 
 Patients on long term steroids 
 Autoimmune disorders. 
HISTORY ELICITED FROM THE PATIENT 
All the relevant details from the patient were elicited using preformed 
proforma.(Annexure) 
COLLECTION OF SAMPLE [20] 
Samples were collected from all patients who gave history of skin, 
scalp or nail lesions clinically diagnosed as superficial fungal infection. 
 Skin scraping 
 Nail clipping 
 Plucked hair. 
 Skin: The lesion was thoroughly cleaned with 70% alcohol and 
allowed to dry. Skin lesion was scrapped from periphery (active 
margin) using flame sterilized blunt scalpel without injuring the skin 
surface. 
 Strongly macerated skin between toes was removed by forceps. 
 Samples from vesicles was collected by gently deroofing with a needle. 
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 Hair: The same procedure as above was followed as for skin scrapings, 
in addition a few affected hairs were also epilated and collected with a 
pair of flame sterilized tweezers. Care was taken to collect the basal 
portion of the hair  
 Nail: The affected nail was meticulously swabbed with 70% alcohol 
.Discolored, dystrophic or brittle nails were clipped as far as back as 
possible from the free edge including the full thickness and scrapings 
were collected from the white spots [66,p884-5] 
TRANSPORT OF SAMPLES:[44] 
 The samples were collected in a sterile  piece of black card board (six 
inches square,folded to form an envelope) which was clipped 
together,labelled and transported. 
 Interdigital space lesions were cleaned with sterile saline and collected 
in sterile swabs and inoculated immediately in culture media. 
PROCESSING OF SAMPLE:[20,43,44,53] 
1)Direct Microscopic examination:  
Direct microscopic examination was done  for all the samples. 
Procedure 
 A large drop of 10% KOH (skin/hair) or 20% KOH (nail) solution 
(Annexure) was placed with  a pastuer pipette on a clean grease free 
glass slide . 
 A part of the sample was transferred into the KOH on the slide. 
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 A clean cover slip was placed gently over the mixture without the 
formation of any air bubbles. 
 The slide was kept at room temperature for 20-30mins (skin/hair 
samples) or overnight.(nail sample). 
 The specimen was observed under low and high power objectives. 
Observation 
The type of hyphae, septation, branching,thickness, arthroconidia and 
other features were studied. 
Yeasts were identified by observing the presence of oval to elongated 
yeast cell with or without pseudohyphae. 
CULTURE [20,43,44,53] 
All samples were cultured irrespective of the direct microscopic 
observation. 
Media 
The scrapings were inoculated in duplicate sets into slopes containing, 
a) SDA with chloramphenicol/gentamicin and 
b) SDA with chloramphenicol/gentamicin and cycloheximide. 
(Annexure). 
One set of SDA was incubated at 370 C and second set at 250 C. 
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c) One set of DTM containing chloramphenicol/gentamicin and 
cycloheximide (Annexure) was also inoculated and incubated at 250 
C. 
IDENTIFICATION OF FUNGAL ISOLATES [41,66] 
Any visible growth on either of the slants was examined for, 
1) Colony morphology (yeast/Mould] ) [43] 
a. Topography 
b. Texture 
c. Surface pigmentation 
d. Pigmentation on reverse 
e. Presence of diffusible pigment 
f. Rate of growth. 
All the SDA tubes were read every day for a week following 
incubation and twice weekly thereafter for 4-6weeks.[20] DTM tubes are read 
for growth and colour change in the medium daily for 7-10 days.[20,46] Tubes 
showing no growth after the specified period were discarded. 
MICROSCOPY [20,44] 
a.Gram staining(Annexure) :Creamy white colonies with features 
suggesting of yeast were Gram stained . 
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Procedure 
 Tiny part of a colony was picked and a smear was prepared. 
 The smear was allowed to dry and heat fixed. 
 The smear flooded with Methyl violet for one minute and excess stain 
poured off. 
 The slide was rinsed in flowing tap water. 
 Gram’s Iodine was added and rinsed in flowing tap water after one minute. 
 Acetone was added and rinsed off with tap water after 2-3secs. 
 Finally the smear was counterstained with dilute carbol fuschin for few secs. 
 The slide was washed in tap water and air dried. 
 The smear was observed under oil immersion objective.  
OBSERVATION: 
Gram reaction, size, shape and arrangement of cells were observed. 
INTERPRETATION 
Gram positive oval to elongated cell-Yeast cell.Presence or absence of 
pseudohyphae are noted. 
LACTOPHENOL COTTON BLUE (LPCB) [45 ] (ANNEXURE) 
LPCB mount was prepared from colonies resembling mould and 
examined for hyphal morphology and its pigmentation,conidia morphology 
(microconidia and macroconidia) and its arrangements.Lactic acid aids in 
preserving the fungal structure;phenol acts as a disinfectant and cotton blue 
imparts color to the structures. 
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Procedure [20,44] 
 A drop of LPCB was placed on a clean dry glass slide. 
 Using a straight mycological loop a tiny portion of the colony to be 
examined was removed from the agar and placed on the stain. 
 With two dissecting needles the mycelial mass was gently well teased 
apart. 
 A cover slip was placed and observed under low and high power 
objectives. 
Interpretation 
Morphology of the isolates was observed and the causative fungus 
identified [20,43,46] 
SLIDE CULTURE [20,43] 
The slide culture technique was done to study the typical morphology 
of the isolate, like arrangement of conidia, without disturbing the relationship 
between reproductive structures and mycelium or the sporulation 
characteristics of the organism. 
PROCEDURE 
 A slide was placed on a bent glass rod in a petridish with cover slip, 
filter paper and the dish was wrapped and sterilized by autoclaving at 
1210C for 15mins. 
 With a sterile scalpel an agar block 1sqcm and 2-3 mm deep was cut 
out of a plate of SDA.This block was transferred onto the center of the 
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sterilised glass slide.With a heavy nichrome wire bend loop,the four 
corners of the agar block were inoculated with the fungal isolate under 
study and the block was covered with the sterilized cover slip. 
 1-1.5ml of sterile distilled water was pipetted on to the filter paper 
placed inside the petri dish so as to prevent drying of the agar block. 
 The plate was incubated at room temperature and examined 
periodically for growth.Once sporulation had well developed,the cover 
slip was carefully separated using a sterile forceps from the agar block 
,flamed quickly to fix the fungus with the spores. 
 Heat fixed cover slip was placed on a drop of LPCB on a second glass 
slide. 
 The agar block was gently flipped off the original slide, few drops of 
LPCB was added and new cover slip was laid over the preparation.Both 
the slides were then examined under microscope.When examination is 
likely to be delayed,the edges of the LPCB mount were sealed with nail 
polish to prevent drying.   
GERM TUBE TEST [20,43] 
Principle 
The in vitro production of germ tubes by Candida albicans, when 
incubated in serum for two hours is noted. 
Procedure 
 It is performed with freshly sub cultured pure growth. 
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 The organism is inoculated onto 0.5ml of serum . 
 Incubated at 370C for two hours. 
 After incubation, the suspension was placed on a clean, dry slide and 
covered with coverslip and observed under low and high power 
objectives. 
Interpretation 
 Germ tube test was considered positive (within two hours)-if 30% of cells 
shows long tube like projection from a mother cell which are non septate 
with parallel sides and no constriction at the point of connection were 
presumptively identified as Candida albicans/Candida dubliniensis. 
 Germ tube negative-Non albicans candida. 
CHROM AGAR  [20]  (ANNEXURE) 
This differential culture media was inoculated to speciate the candida 
isolates.Isolates from primary medium (SDA) were subcultured in SDA and 
single yeast colony was streaked onto the Chromagar plates.Incubated at 370 
C for 48-72hrs. 
Interpretation: 
C.albicans           Light green 
C.dubliensis        Dark green 
C.glabrata           Pink to purple 
C.krusei              Pink 
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C.parapsilosis     Cream to pale pink 
C.tropicalis          Blue with pink halo. 
BIOCHEMICAL REACTION 
UREA HYDROLYSIS [43,44] 
Modified Christensen’s medium (Annexure) for urea hydrolysis was 
used to distinguish T.mentagrophytes from T.rubrum.  
Procedure 
The slopes were inoculated with a small amount of the fungal culture 
and was incubated at room temperature along with a control tube . The results 
were noted for 2-5days 
Interpretation 
 Urease positive (deep pink) within 4days  -T.mentagrophytes 
 Urease negative - T.rubrum. 
SUGAR FERMENTATION TEST [20,43] (ANNEXURE) 
 A loopful of 24-48hrs culture from a sugar free media was suspended 
in sterile distilled water. 
 0.1ml of this suspension was added to 2% sugar fermentation media 
with Bromothymol blue indicator. 
 Dextrose,lactose,sucrose,maltose,galactose and trehalose were tested. 
 Inoculated sugars were incubated at 250C for 48-72hrs. 
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 The ability to ferment a sugar was noted by the production of acid and 
the presence of gas in Durham’s tube. 
INTERPRETATION [43] 
Species Dextrose Lactose Sucrose Maltose Galact Trehal
C.albicans F NF NF F F F 
C.tropicalis F NF F NF NF NF 
C.parapsilosis F NF NF NF NF NF 
C.glabrata F NF NF NF NF NF 
C.krusei NF NF NF NF NF NF 
C.guillermondii NF NF NF NF NF NF 
C.kefyr NF F F NF F NF 
F-Fermented                NF-Not fermented 
IN VITRO HAIR PERFORATION TEST [43,46] 
Hair perforation test was done to differentiate between 
T.mentagrophytes and T.rubrum.Growth of the fungus in artificial culture 
media along with the hair was observed. 
 Procedure 
 1cm human hair from a child <5years was placed in a petridish and 
autoclaved at 1210C for 10mins. 
 To it 25ml of sterile distilled water , 2-3drops of filter sterilized 10% 
yeast extract (Annexure)were added. 
 The plate was inoculated with a small fragment of the test fungi. 
 The plate was incubated at room temperature (250C) for 4weeks. 
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 Periodically each hair strands were removed, mounted on a slide 
containing LPCB and examined under low/high power objectives.  
Interpretation 
 Positive (wedge shaped perforation)-T.mentagrophytes and all 
Microsporum species 
 Negative-T.rubrum. 
ANTIFUNGAL SUSCEPTIBILITY TESTING [46] 
Microbroth dilution method: Evaluation of MIC 
Antifungal agents 
Source: Antifungal standards or reference powder with its assay 
potency in µg/ml or IU/mg. 
Weighing antifungal powders: Can be derived by using either of the 
formulae. 
   Vol(ml)XConc(µg/ml) 
Weight(mg) of drug  ---------------------------- 
    Assay potency (µg/mg) 
 
    Weight(mg) X Assay potency (µg/mg) 
Volume of Diluent(ml)= ---------------------------------------------- 
      Conc: (µg/ml) 
Preparation of stock solution 
 Antifungal stock solutions were prepared at a concentration of 
1280µg/ml for water soluble drug and 1600µg/ml for water insoluble 
drug. 
 65
 Water soluble drug like Fluconazole was dissolved in distilled water 
and two dilution was prepared as given in Chart 1. 
 Water insoluble drugs, Amphotericin B, Itraconazole, Ketoconazole, 
Voriconazole and terbinafine were dissolved DMSO and diluted with 
RPMI 1640.Dilution were prepared following Chart-2. 
Number of concentrations tested 
 Amphotericin B 0.0313 to 16µg/ml 
 Ketoconazole 0.0313 to 16µg/ml 
 Itraconazole 0.0313 to 16µg/ml 
 Voriconazole 0.0313 to 16µg/ml 
 Fluconazole 0.125 to 64µg/ml 
 Terbinafine 0.0313 to 16µg/ml 
Medium: Rosewell Park memorial institute (RPMI) 
1640(Annexure)with glutamine without bicarbonate. 
Buffer: MOPS (3-N-Morpholino prophanesulfonic acid) 
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CHART-1 :SCHEME  FOR PREPARING DILUTIONS OF WATER SOLUBLE DRUGS 
Drug(µg/ml) Stock 5120 2 4 8 16 32 64 128 256 512 Remark 
TUBE TUBE 1 2 3 4 5 6 7 8 9 10  
SOURCE 
DRUG(ml) 
From stock 
1.0 
T-1 
1.0 
T-1 
1.0 
T-3 
1.0 
T-3 
0.5 
T-3 
0.5 
T-6 
1.0 
T-6 
0.5 
T-6 
0.5 
T-9 
1.0 
Step 1 
Row 1 
RPMI 1640 7.0 1.0 3.0 1.0 1.5 3.5 1.0 1.5 3.5 1.0  
INTERMEDITE 
DRUG CONC.(µg/ml) 
640 320 160 80 40 20 10 5 2.5 1.25  
Add drug from Row1(ml)+RPMI(ml) 1+4 1+4 1+4 1+4 1+4 1+4 1+4 1+4 1+4 1+4 Step 2 
Row  
5x(1:4) 
Final concentration 
1:5(µg/ml) 
128 64 32 16 8 4 2 1 0.5 0.25 2X 
From Row 2 add drug to plate(ml) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Step 3 
1:1 
Inoculum (ml) to plate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Step 4 
Final drug conc: 
In each well  
1:100 µg/ml) 
64 32 16 8 4 2 1 0.5 0.25 0.125  
T= Tube 
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CHART 2 :SCHEME FOR PREPARING DILUTIONS OF WATER INSOLUBLE DRUGS 
Drug(µg/ml) Stock 2 4 8 16 32 64 128 256 512 Remark 
TUBE TUBE1 2 3 4 5 6 7 8 9 10  
SOURCE 
DRUG(ml) 
From 
stock 
1.0 
T-1 
0.5 
T-1 
0.5 
T-1 
0.5 
T-4 
0.5 
T-4 
0.5 
T-4 
0.5 
T-7 
0.5 
T-7 
0.5 
T-7 
0.5 
STEP 1 
ROW 1 
Solvent DMSO(ml) - 0.5 1.5 3.5 0.5 1.5 3.5 0.5 1.5 3.5  
INTERMEDITE 
DRUG CONC. 
 
1600 
 
800 
 
400 
 
200 
 
100 
 
50 
 
25 
 
12.5 
 
6.25 
 
3.13 
 
Adddrug from 
T1Row1(ml)+RPMI(ml) 
0.1+4.9 0.1+4.9 0.1+4.9 0.1+4.9 0.1+4.9 0.1+4.9 0.1+4.9 0.1+4.9 0.1+4.9 0.1+4.9 STEP 2 
ROW2 
(1:50) 
Final concentration 
1:50(µg/ml) 
32 16 8 4 2 1 0.5 0.25 0.125 0.0625 2X 
From Row 2 add drug 
to plate(ml) 
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 STEP 3 
1:1 
Inoculum (ml) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 STEP 4 
T.Vol0.2ml 
Final drug conc: 
In each well  
1:100 (µg/ml) 
16 8 4 2 1 0.5 0.25 0.125 0.0625 0.0313  
T-Tube 
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YEAST (CANDIDA):CLSI M27-A 2nd  Ed [46] 
Reference strain-Candida albicans ATCC ®90028 
Test strains: Isolated Candida species 
Preparation of inoculum 
 All isolates were subcultured onto SDA. 
 After 48hrs,five identical colonies of 1mm (dia) were picked and 
suspended in 5ml of sterile normal saline. 
 The suspension was vortexed for 15secs and the cell suspension was 
adjusted to 0.5McFarland standards (1-5x106cells/ml). 
 A working suspension of 1:5 (1-5x103CFU/ml) was prepared using 
RPMI as diluent. 
Drugs tested 
 Amphotericin B  
 Fluconazole  
 Voriconazole  
 Itraconazole  
Procedure of microbroth dilution 
 100µl of each drug added through wells 1 to 10 according to the 
concentration prepared. 
 100µl of the inoculum added to all wells making a final concentration 
of inoculum to 0.5-2.5x103 CFU/ml. 
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 The microtiter plates were kept at 350 C for 48hrs. 
Interpretation: MIC for azoles was determined by noting 80% inhibition of 
growth while for Amphotericin B, 100% growth inhibition. 
DRUG MIC range µl/ml Sensitive Resistant 
Amphotericin B 0.0313-16 <1µg/ml >1µg/ml 
Fluconazole 0.125-64 <8µg/ml >8µg/ml 
Itraconazole 0.0313-16 <0.25µg/ml >0.25µg/ml 
Voriconazole 0.0313-16 <1µg/ml >1µg/ml 
DERMATOPHYTES AND NON DERMATOPHYTES 
MOULDS 
METHOD: CLSI M-38A 2nd edition was followed.[46,58,59] 
Reference strain 
 C.parapsilosis ATCC® 22019-Dermatophytes[90-92] 
KORTING, H.C.;et al(1995) stated that no standard reference method 
for determination of MIC to dermatophyte is  available, hence broth 
microdilution method (CLSI M38A)which gives good correlation with clinical 
outcome can be followed. 
 A.flavus ATCC® 204304-Non dermatophytic moulds 
Test strains:All isolated dermatophytes and non dermatophyte moulds 
Preparation of inoculum 
 All strains were freshly subcultured onto SDA 
 After colonies had well grown in the tube, they were filled with 10 ml 
of distilled water. 
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 The inoculum was prepared by scraping the surface of the colonies 
with the tip of a sterile loop. 
 The inoculum thus obtained was transferred to another sterile tubes and 
left for 15 to 20 minutes at room temperature to sediment the heavy 
particles.  
 The optical density of the suspensions containing conidia and hyphal 
fragments was read at 530 nm, adjusted to transmittance of 65 to 70% 
(2 to 4 X 106 cells/mL) and further diluted with RPMI 1640 medium to 
obtain the final inoculum size of 0.4 to 5 X 104 cells/mL. 
Drugs tested 
 Terbinafine 
 Ketoconazole  
 Itraconazole  
 Voriconazole 
 Amphotericin B 
Procedure of microbroth dilution 
 100µl of each drug added through wells 1 to 10 according to the 
concentration prepared. 
 100µl of the inoculum added to all wells making a final concentration 
of inoculum to 0.2-2.5x104 CFU/ml. 
 Incubation temperature & time for dermatophytes-240C/4-5days 
 71
 Incubation temperature & time for Non dermatophytes-350 C/24-48hrs. 
Interpretation  
MIC for azoles was determined by noting 80% inhibition of growth while 
for terbinafine, 100% growth inhibition. 
DRUGS MIC range µl/ml Sensitive Resistent 
Terbinafine 0.0313-16 <0.25 >0.25 
Itraconazole 0.0313-16 <0.5* >0.5* 
Voriconazole 0.0313-16 <0.250 >0.250 
Amphotericin B 0.0313 -16 <2 >2 
Ketoconazole 0.0313 -16 <2 >2 
* For NDM MIC=<1.0 (S);>1.0(R) 
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RESULTS 
TABLE-1:  AGE WISE DISTRIBUTION OF STUDY 
POPULATION (n=150) 
Age group (years) No.of cases (n) Percentage (%) 
21-30 2 1.3 
31-40 24 16 
41-50 52 34.6 
51-60 38 25.3 
61-70 18 12 
71-80 14 9.3 
81-90 2 1.3 
The study population consisted of patients in the age of 26-85 years. 
There was preponderance of cases in the 41-50years age group population.  
(p=0.8315,Fischer’s exact test) 
Fig-1: Age Distribution 
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TABLE:2 GENDER WISE DISTRIBUTION OF STIDY 
POPULATION (n=150) 
 Male Percentage Female Percentage Total Ratio (M:F) 
No.of case(n) 78 52% 72 48% 150 1.06:1 
The study population consisted of 78 (52%) males and 72(48%) 
females and the Male:female ratio was 1.06:1.(p=0.1410.Fischer’s exact test) 
Fig-2: Male Vs Female 
 
TABLE-3: DISTRIBUTION OF DIABETES MELLITUS IN 
STUDY POPULATION(N=150) 
 Type-I Percentage Type-II Percentage Total 
No.of case(n) 18 12% 132 88% 150 
Type II diabetes were more affected than the type 
I.(p=0.6190,Fischer’s exact test)  
Fig-3: Type of Diabetes 
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TABLE-4: SAMPLES COLLECTED FROM STUDY 
POPULATION (n=150) 
S.No Specimen No.of sample collected (n) Percentage (%) 
1. SKIN 63 42 
2. NAIL 87 58 
 TOTAL 150 100 
The total samples collected from skin scrappings were 63(42%)and 
from the nail clippings 87 (58%). 
Fig-4: Skin Vs Nail 
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TABLE-5: DISTRIBUTION OF DERMATOMYCOSIS IN THE 
STUDY POPULATION (n=63) 
S.No Clinical classification No.of.case(n) Percentage% 
1. Tinea capitis 0 0 
2. Tinea faciei 1 1.5 
3. Tinea barbae 1 1.5 
4. Tinea corporis 40 63.4 
5. Tinea manuum 2 3.1 
6. Tinea cruris 14 22.2 
7. Tinea pedis 2 3.1 
8. Web space 3 4.7 
 TOTAL 63  
The predominant dermatomycotic lesion was tinea corporis which  
accounted for 40 (63.4%) cases followed by tinea cruris 14(22.2%),tinea pedis 
2(3.1%) and web space infection 3(4.7%).  
Fig-5: Skin Lesion 
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TABLE-6: DISTRIBUTION OF ONYCHOMYCOSIS IN THE 
STUDY POPULATION(n=87) 
S.No Clinical classification No.of cases(n) Percentage(%) 
1. DLSO 58 66.6 
2. PSO 3 3.4 
3. WSO 21 24.1 
4. TDO 5 5.7 
 TOTAL 87  
The predominant onychomycotic lesion was DLSO which accounted 
for 58(66.6%) cases followed by WSO in 21 (24.1%) cases. 
Fig-6: Nail Lesion 
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TABLE-7: EVALUATION OF KOH MOUNT(n=150) 
S.No SAMPLE KOH Positive(%) KOH Negative(%) TOTAL 
1. SKIN 35 28  63 
2. NAIL 30 57  87 
 TOTAL 65 (43) 85 (56) 150 
The direct microscopic examination (KOH) was positive in 65 (43%) 
samples and was negative in 85 (56%) samples.  
Fig-7: Samples Vs KOH 
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TABLE-8: EVALUATION OF CULTURE(n=150) 
S.No SAMPLE Culture Positive(%) Culture  Negative(%) TOTAL
1. SKIN 39  24  63 
2. NAIL 34 53  87 
 TOTAL 73 (48) 77 (51) 150 
The total number of samples which showed growth in cultures were 
73(48%) and 77 (51%) samples showed no growth in cultures. 
Fig-8: Sample Vs Culture 
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TABLE-9: CORRELATION BETWEEN DIRECT 
MICROSCOPY (KOH) AND CULTURE (n=150) 
S. 
No Lesion 
Koh+ve 
culrure +ve 
Koh+ve 
culture -ve 
Koh-ve 
culture +ve 
Koh-ve 
culture -ve Total
1. Tinea faciei - - 1 - 1 
2. Tinea barbae - - 1 - 1 
3. Tinea corporis 13 2 7 18 40 
4. Tinea manuum 1 - 1 - 2 
5. Tinea cruris 6 2 4 2 14 
6. Tinea pedis 1 - - 1 2 
7. Web space - - 2 1 3 
8. Tinea 
Unguium 
14 24 20 29 87 
TOTAL 35 (23.3%) 28 (18.6%) 36 (24%) 51 (34%) 150 
A total of  35(23.3%) samples were positive on direct examination and 
culture and 51(34%) samples were negative by both the tecniques.Samples 
positive by direct examination  and negative on culture was 28(18.6%). 
Further 36 (24%) samples isolated on culture were negative on direct 
examination. (p=0.4175;Fischer exact test ) 
Fig-9:KOH Vs Culture 
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TABLE-10: ISOLATES OF SUPERFICIAL MYCOSES IN THE 
STUDY POPULATION (n=73) 
S.No ISOLATES SKIN NAIL TOTAL Percentage
1. DERMATOPHYTE 33(84%) 14(41%) 47 64.3% 
2. CANDIDA 6(15%) 11(32%) 17 23.2% 
3. NONDERMATOPHYTE 0 9(26%) 9 12.3% 
TOTAL 39 34 73  
The predominant pathogen isolated from skin and nail was 
dermatophytes followed by candida species.Non dermatophyte moulds were 
isolated from nail lesions. 
Fig-10a: Skin Lesion Culture 
 
Fig-10b: Nail Lesion Culture 
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TABLE-11: CLINICOMYCOLOGICAL PATTERN OF 
SUPERFICIAL MYCOSES (n=73) 
Dermatophytes Candida Nondermatophytes S. 
No 
Clinical 
lesion T.m T.r T.t T.v C.p C.t C.g Rhi Fus A.f A.n
1. Tinea faciei _ 1 _ _ _ _ _ _ _ _ _ 
2 Tinea barbae 1 _ _ _ _ _ _ _ _ _ _ 
3 Tinea corporis 15 4 1 1 _ _ _ _ _ _ _ 
4 Tinea 
manuum 
1 _ _ _ _ 1 _ _ _ _ _ 
5 Tinea cruris 3 3 _ 1 1 2 _ _ _ _ _ 
6 Tinea pedis 1 1 _ _ _ _ _ _ _ _ _ 
7 Web space _ _ _ _ _ 1 1 _ _ _ _ 
8 Tinea 
unguium 
12 2 _ _ 1 7 3 4 2 2 1 
TOTAL 33 11 1 2 2 11 4 4 2 2 1 
Percentage(%) 45.2 15 1.3 2.7 2.7 15 5.4 5.4 2.7 2.7 1.3 
The predominant isolate among the dermatophyte was Trichophyton 
mentagrophytes which accounted for 33 (45%) followed by Trichophyton 
rubrum in 11(15%) cases.The predominant isolates among candida was 
candida tropicalis which accounted for 11(15%) and in nondermatophyte 
moulds it was Rhizopus 4(5.4%) followed by Fusarium and A.fumigatus 
2(2.7%) cases each. 
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Fig-11 (a): Dermatophytes 
 
 
Fig-11 (b): Candida 
 
 
Fig-11 (c): Non Dermatophyte Mould 
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TABLE-12: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF TERBINAFINE TO THE ISOLATED 
DERMATOPHYTES (n=47) 
S.No STRAIN No.of.Isolates
Sensitive 
MIC<0.250
Resistence 
MIC>0.250 
MIC 
µg/ml 
1. C.parapsilosis 
ATCC® 22019 
 
1 1(100%) _ 0.125 
2 T.mentagrophytes 33 33(100%) _ 0.0625-
0.250 
3 T.rubrum 11 9(81%) 2*(18%) 0.0313-
0.125 
4 T.tonsurans 1 1(100%) _ 0.0625 
5. 
 
T.verrucosum 2 2(100%) _ 0.0625-
0.125 
 
All isolates were sensitive to terbinafine except for two strains of 
T.rubrum 
*MIC=0.5µg/ml and 16µg/ml 
Fig-12  
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TABLE-13: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF KETOCONAZOLE TO THE ISOLATED 
DERMATOPHYTES (n=47) 
S.No STRAIN No.of.Isolates
Sensitive
MIC<2 
Resistence 
MIC>2 
Mean 
MICµg/ml
1. C.parapsilosis 
ATCC ®22019 
 
1 1(100%) _ 0.250 
2 T.mentagrophytes 33 33 
(100%) 
_ 0.125-1 
3 T.rubrum 11 10(96%) 1*(4%) 0.125-1 
4 T.tonsurans 1 1(100%) _ 0.5 
5. 
 
T.verrucosum 2 2(100%) _ 0.250-1 
All  isolates  were  sensitive  to  ketoconazole  except  for  one  strain  of 
T.rubrum.*MIC=4µg/ml 
Fig-13 
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TABLE-14: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF ITRACONAZOLE TO THE ISOLATED 
DERMATOPHYTES (n=47) AND NONDERMATOPHYTE 
MOULDS (n=9) 
S.No STRAIN No.of. Isolates
Sensitive 
MIC<0.250*
Resistence 
MIC>0.250 
Mean 
MICµg/ml 
1. C.parapsilosis 
ATCC ®22019 
 
1 1(100%) _ 0.125 
2 T.mentagrophytes 33 33 (100%) _ 0.0625-0.250 
3 T.rubrum 11 10(96%) 1**(4%) 0.0313-0.125 
4 T.tonsurans 1 1(100%) _ 0.125 
5. T.verrucossum 2 2(100%) _ 0.125-0.250 
6 A.flavus ATCC 
®204304 
1 1(100%) _ 0.250 
7 A.fumigatus 2 2(100% _ 0.25-0.5 
8 A.nidulans 1 1(100%) _ 0.5 
9 Rhizopus spp 4 4(100% _ 0.25-1 
10 Fusarium spp 2 2(100%) _ 0.25-1 
*For dermatophytes MIC=<0.250 µg/ml is sensitive and for nondermatophyte 
moulds MIC=-<1µg/ml 
All isolates were sensitive to itraconazole except for one strain of T.rubrum 
**MIC=16.0µg/ml. 
Fig-14:  
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TABLE-15: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF VORICONAZOLE TO THE ISOLATED  
NONDERMATOPHYTE MOULDS (n=9) 
S.No STRAIN No.of.Isolates
Sensitive 
MIC<0.250
Resistence 
MIC>0.250 
Mean 
MICµg/ml 
1. A.flavus 
ATCC 
®204304 
 
1 1(100%) _ 0.125 
2 A.fumigatus 2 2(100% _ 0.0625-
0.125 
3 A.nidulans 1 1(100%) _ 0.250 
4 Rhizopus 
spp 
4 4(100% _ 0.125-
0.250 
5. 
 
Fusarium 
spp 
2 2(100%) _ 0.0625-
0.25 
All isolates were sensitive to voriconazole. 
Fig-15 
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TABLE-16: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF AMPHOTERICIN B TO THE ISOLATED  
NONDERMATOPHYTE MOULDS (n=9) 
S. 
No STRAIN No.of.Isolates 
Sensitive
MIC<2 
Resistence 
MIC>2 
Mean 
MICµg/ml
1. A.flavus ATCC 
®204304 
 
1 1(100%) _ 0.250 
2 A.fumigatus 2 2(100% _ 0.5-1 
3 A.nidulans 1 1(100%) _ 1.0 
4 Rhizopus spp 4 4(100% _ 0.5-2 
5. Fusarium spp 2 2(100%) _ 0.5-1 
All isolates were sensitive to amphotericin B 
Fig-16 
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TABLE-17: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF AMPHOTERICIN B TO THE ISOLATED  
CANDIDA (n=17) 
 
S.No STRAIN No.of.Isolates
Sensitive
MIC<1.0
Resistence 
MIC>1.0 
Mean 
MICµg/ml 
1. Candida 
albicans 
ATCC® 90028 
 
1 1(100%) _ 0.125 
2 C.tropicalis 11 11(100% _ 0.125-0.5 
3 C.parapsiosis 2 2(100%) _ 0.0625-
0.25 
4 C.glabrata 4 4(100% _ 0.125-0.5 
All isolates were sensitive to amphotericin B. 
Fig-17 
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TABLE-18: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF FLUCONAZOLE TO THE ISOLATED  CANDIDA 
(n=17) 
 
S. 
No STRAIN No.of.Isolates
Sensitive
MIC<8 
Resistence 
MIC>8 
Mean 
MICµg/ml
1. Candida albicans 
ATCC® 90028 
 
1 1(100%) _ 4 
2 C.tropicalis 11 11(100% _ 0.5-1.0 
3 C.parapsiosis 2 2(100%) _ 1.0-2.0 
4 C.glabrata 4 4(100% _ 0.5-1 
All isolates were sensitive to fluconazole. 
Fig-18 
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TABLE-19: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF ITRACONAZOLE TO THE ISOLATED  CANDIDA 
(n=17) 
 
S. 
No STRAIN No.of.Isolates
Sensitive 
MIC<0.250
Resistence 
MIC>0.250 
Mean 
MICµg/ml
1. Candida 
albicans 
ATCC 
®90028 
 
1 1(100%) _ 0.250 
2 C.tropicalis 11 11(100% _ 0.125-
0.250 
3 C.parapsiosis 2 2(100%) _ 0.125-
0.250 
4 C.glabrata 4 4(100% _ 0.0125-
0.250 
All isolates were sensitive to itraconzole. 
Fig-19 
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TABLE-20: ANTIFUNGAL SUSCEPTIBILITY PATTERN 
(MIC) OF VORICONAZOLE TO THE ISOLATED  CANDIDA 
(n=17) 
S.No STRAIN No.of.Isolates
Sensitive
MIC<1.0
Resistence 
MIC>1.0 
Mean 
MICµg/ml 
1. Candida 
albicans 
ATCC® 90028 
 
1 1(100%) _ 0.0625 
2 C.tropicalis 11 11(100% _ 0.125-0.5 
3 C.parapsiosis 2 2(100%) _ 0.0625-
0.250 
4 C.glabrata 4 4(100% _ 0.5-1 
All isolates were sensitive to voriconazole. 
Fig-20 
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DISCUSSION 
A total of 150 diabetic patients who attended dermatology/ diabetology 
OPDs and was diagnosed as a case of superficial mycoses were studied during 
one year period (Oct 2011 to Sept 2012).                            
The age group of the patients were from 26 to 85, the mean age being 
55.5years, [Table-1] same as that studied by Ditte Maria et al(2006) in 26-
91yrs[62].The common age groups affected were between 41-60,which was 
similar to Blanka Havlickova et al (2008) who found in 44-57years age 
grours.[74,82] 
Statitical analysis of the age factor (Fischer’s exact test, p=0.8315) 
showed no significant difference in the occurrence of infection. 
There were 78 males (52%) and 72 females (48%) [Table2] similar to 
M.Situm et al (1998) who found in 59% males and 41% females and also 
Kennedy et al (2007) who found in 53% and 47% respectively and stated that 
most studies in and around Chennai showed a male dominance[62,64,66,67,82]. 
The male to female ratio was 1.06:1. [Table-2] which correlated with 
that of Kennedy et al, Chennai, 1.12:1[77,86]. Heoprich et al (1994) has 
attributed the male preponderance to hormonal factor and P Veer (2007) et al  
to their more outdoor activities hence prone to trauma. 
Statitical analysis of the gender (Fischer’s exact test, p=0.1410) 
showed no significant difference in the occurrence of infection. 
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The distribution of type of diabetic patients in the study group 
were,typeI 12% and typeII 88% [Table3] ,similar to Eckhard et al(2007) who 
found in 18% and 82% respectively.[30,62,64] Statitical analysis of the type of 
diabetes (Fischer’s exact test , p=0.6190) showed no significant difference in 
the occurrence of infection. 
Out of the 150 diabetic patients studied 47 showed PPBS <160mg% 
(controlled DM) and 103 showed PPBS>160mg% (uncontrolled DM).The 
infection rate among the controlled was 59% and that in uncontrolled 43%. 
Statitical analysis (Fischer’s exact test, p=0.08) showed no significant 
difference in the occurrence.Hence all diabetic patients are at the same risk of 
acquiring the infection. 
Thus diabetic patients are susceptible to superficial mycoses 
irrespective of their age, gender, type of DM and blood sugar level ..[7,62] 
A  total of 63 skin and 87 nail samples were collected. [Table-4] as 
shown by Phoebe Rich et al that the onychomycosis was the most common 
infection among diabetic patients.[57,62,64,69]. 
Among the skin lesions,tinea corporis was the predominant [75,77-79,81,86] 
which occurred in 40(63.4%) patients followed by tinea cruris in 14(22.2%), 
tinea pedis 2(3.1%) and web space infection in3(4.7%). [Table-5]. Mixed 
infection were noted  in 2 cases,comprising of tinea corporis and tinea 
manuum;tinea pedis and toe web space infectionsVerenkar MP et al(1991) has 
stated that the high incidence of tinea corporis and tinea cruris was probably 
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due to its symptomatic nature (pruritic) which leads the patient to seek 
medical advice. 
Among nail infections distal and lateral subungual kertatosis was the 
predominant lesion which occurred in 58(66%) cases similar to Garg et 
al(2004) of 64.4% [Table-6].[68,82,85]. 
Out of 150 clinically diagnosed cases, direct microscopic 
examination(KOH) showed positivity in 35 skin  lesions and  in  30  nail 
samples .Thus the total KOHpositivity was 65(43%) [Table-7]. which was 
similar to JC Mohanty et al 43%(1999).[72]  
The causal agents were isolated by culture in 39 skin lesions and in 34  
nail samples. [Table-8]. Thus the total culture positivity was 73(48%) which 
only slightly varied with Pankajalakshmi et al, Chennai(1981) 44%,Sharma N 
L et al,Shimla(1987)45% and Mallick AK et al,Rohtak (1996) 53%. 
Thus a  total of  35(23.3%) samples were positive on direct 
examination and culture which was similar to Mallick AK et al 23%(1996) 
and slightly lower than Vasu BH et al,Warangal(1966) 26%.[Table-9] 
Samples negative by both the techniques was 51(34%).Samples 
positive by direct examination and negative on culture was 28(18.6%). 
Further 36 (24%) sample isolated on culture were negative on direct 
examination [Table-9] which was slightly less than JC Mohanty et al 30% 
(1997). (p=0.4175; Fischer exact test, no statistical significant difference in 
the diagnostic efficacy) 
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In skin lesions, dermatophyte was the major pathogen isolated which 
accounted for 33(84%) out of culture positive cases followed by candida species 
6(15%) [Table-10] as shown by A Lugo.Somolinos et al that 15% of isolates in 
diabetes were candida. [62, 75.77, 81, 93]. Among the candida species the predominant 
species isolated from skin was Candida tropicalis, 4(66%) [Table-11]. 
Among the dermatophytes,Trichophyton mentagrophytes  21(63%) was 
the commonest strain followed by Trichophyton rubrum, 9(27%) [Table-11], 
similar to M.Situm et al (1998) and   Romano C et al (2001studies) [26,74] 
In nail infection, dermatophyte was the major pathogen which 
accounted for 14(41%) out of the culture positive cases followed by candida 
11(32%) and nondermatophyte mould 9(26%) [Table-11] 
Among the dermatophytes isolated in nail samples, Trichophyton 
mentagrophytes 12(85%) was the commonest followed by Trichophyton rubrum 
(14%) [Table-11] similar to Macura AB et al (2007) [26]. The candida species isolated 
in nail was also predominantly Candida tropicalis 7(63%). [Table-11]. 
The predominant variant was Trichophyton mentagrophytes var inter 
digitale (anthropophilic) and two isolates were Trichophyton mentagrophytes 
var mentagrophytes (Zoophilic). 
The total nondermatophytes isolated in nail lesions (repeat isolate) was 
9(26%), [Table-11], namely Rhizopus spp, Fusarium spp and Aspergillus spp 
[66,70,95,96,98]. As Wg Cdr Grover S et al (2003) stated that NDM colonises the 
damaged tissues and can cause infection in diabetic patients and moreover 
Mohammad Rahbar et al (2010) explained that the spores of NDM which are 
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ubiquitous in the environment can transiently colonise healthy skin and 
causes debilitating disease in immunocompromised patients. 
Infection with two strains were noted in one case comprising of 
Trichophyton mentagrophytes and Candida parapsilosis of toe nail similar to 
that showed by Mohammad Rahbar et al(2008). [26,97,98]. 
The antifungal susceptibility pattern (MIC),of the isolates were 
studied. Among dermatophytes ,all isolates were sensitive to 
terbinafine,itraconazole and ketoconazole except two strains . [Table-12-14] 
Out of the resistant strains ,one (T.rubrum) was resistant to all the three drugs 
and the other (T.rubrum) to terbinafine. [89,97,99]. 
 Lisa Matricciani et al (2011) has contributed hyperglycaemia as the reason for 
drug resistance.In this study the multidrug resistant patient had PPBS of 425mg%. 
Colin.S.osborne et al (2005) has found that some strains of T.rubrum 
isolated from diabetic patient with onychomycosis showed intrinsic resistance 
to terbinafine which on prolonged exposure to the drug can raise the MIC 
values.Similar findings were shown by Pranab K.Mukherjee et al (2003). 
Cervelatti EP et al (2006) and Fachin AL et al(2006) has detailed the 
involvement of ABC transporter gene in the development of resistance to 
azoles inT.rubrum. 
The candida species (17) which were tested against amphotericin B, 
itraconazole and voriconazole, fluconazole [Table-17-20] and the 
nondermatophyte moulds (10) to amphotericin B, itraconazole and 
voriconazole showed 100% sensitivity pattern. [Table-14-16]. 
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SUMMARY 
Out of the 150 diabetic patient with superficial mycoses studied, 
 Male to female ratio was 1.06:1. 
 The commonest age group affected were 41-50 (34%) followed by 51-
60(25%). 
 It was more common in type II than in type I diabetes mellitus. 
 It occured in all diabetic patients irrespective of their age, gender,type 
of DM and blood glucose levels. 
 The commonest skin lesion was tinea corporis 40(63%) followed by 
tinea cruris 14(22%). 
 The commonest nail lesion was distal and lateral subungual 
onychomycosis (DLSO) 58(66%). 
 The direct microscopy (KOH) was positive in 65(43%) and culture in 
73(48%) of clinically diagnosed cases. 
 Isolation rate in culture medias namely SDA and DTM were the same 
but earliest in DTM (5-7days). 
 The commonest isolates in skin were dermatophytes 33(84%) followed 
by candida 6(15%) and in nails,dermatophytes 14(41%),candida 
11(32%) and nondermatophyte 9(12%). 
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 Among the total dermatophytes isolated, T.mentagrophytes 33(45%) 
was the commonest pathogen and in Candida species,C.tropicalis 
11(15%) . 
 Among the total dermatophytes isolated, two isolates showed 
resistance to antifungal agents.One was to all the three 
drugs(Terbinafine,ketoconazole and itraconazole) and other to 
terbinafine alone. 
 All the candida species showed 100% sensitivity to amphotericin 
B,Itraconazole,Fluconazole and voriconazole. 
 Nondermatophyte moulds also showed 100% sensitivity to 
amphotericin B,Itraconazole, and voriconazole. 
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CONCLUSION 
Diabetes is increasing worldwide and the mortality due to diabetic foot 
syndrome is also on the rise.Superficial mycoses accounts the common 
cutaneous manifestation and especially onychomycosis which can act as a 
chronic reservoir. Due to associated complications like neurovasculopathy, 
obesity and hyperglycaemia,the tissues are further damaged before the patient 
can recognise the lesion.The chronicity and tissue disruption can lead to 
secondary bacterial infection. 
Clinical suspicion, early laboratory examination to confirm diagnosis 
and appropriate treatment is very crucial in this group of patients. 
Diabetic patients are susceptible to superficial mycoses irrespective of 
their age, gender, type of DM and blood sugar level as proved with statistical 
analysis.Thus their immunosuppressive state is the main risk factor. 
Direct microscopic examination and culture identification plays the 
major part in the management.Though Sabouraud dextrose agar with 
antimicrobials which needs incubation for 4-8weeks,is the commonly used 
media for isolation, Dermatophyte test medium which give presumptive 
identication within a week can be used instead in these group of patients. 
Apart from dermatophytes which is the commonest isolates in 
superficial mycoses, other agents like Candida and non dermatophyte moulds 
which were considered as contaminants or coloniser is also emerging as a 
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pathogen especially in these group of patients.Hence repeated isolation will 
prove its pathogenicity. 
Though early complete course of treatment gives mycological cure, 
resistant strains are also occurring which can act as a chronic reservoir of 
infection.Hence routine antifungal susceptibility testing especially in these 
group of patients for whom mycological cure can save a limb has to be done 
routinely for timely interventions.   
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LIST OF ABBREVIATIONS 
AFST : Antifungal susceptibility testing 
ATCC : American type culture collection 
A.f                                    :    Aspergillus fumigatus 
A.n                                   :     Aspergillus nidulans 
CLSI : Clinical and laboratory standard institute 
C.g : Candida glabrata 
CMA : Corn meal agar 
C.p : Candida parapsilosis 
C.t : Candida tropicalis 
DM : Diabetes mellitus 
DMSO : Dimethyl sulphoxide 
DLSO : Distal and lateral subungual onychomycosis 
DTM : Dermatophyte test medium 
Fus                                    :    Fusarium species 
GT : Germ tube  
KOH : Potassium hydroxide 
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LPCB : Lactophenol cotton blue 
MIC : Minimum inhibitory concentration 
NDM : Non dermatophyte mould 
PPBS                                :     Post prandial blood sugar 
PDA : Potato dextrose agar 
PSO : Proximal Subungual Onychomycosis 
Rhi                                    :     Rhizopus species 
RPMI : Rose Parkwell memorial institute. 
SDA : Sabouraud’s dextrose agar 
SAP : Secretory aspartyl proteases 
TDO : Total Dystrophic Onychomycosis 
T.m : Trichophyton mentagrophytes 
T.r : Trichophyton rubrum 
T.t : Trichophyton tonsurans 
T.v : Trichophyton verrucosum 
WSO : White Superficial Onychomycosis 
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PROFORMA 
NAME:                                   AGE/SEX:                               OP/IP: 
OCCUPATION: 
PRESENT COMPLAINTS: 
SITE OF LESION: 
PRIMARY/RELAPSE: 
PET ANIMALS: 
TYPE OF DM: 
DURATION OF DM: 
B.SUGAR: 
TREATMENT HISTORY: 
FAMILY H/O DM & LESIONS 
SAMPLE:SKIN/NAIL/HAIR 
LAB INVESTIGATION: 
KOH MOUNT: 
CULTURE:SDA 
                   DTM 
GRAM STAIN: 
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LPCB MOUNT: 
SLIDE CULTURE:  
UREA HYDROLISIS TEST 
IN VITRO HAIR PERFORATION TEST: 
GERM TUBE TEST: 
CHROM AGAR: 
FERMAENTATION OF SUGAR 
INTERPRETATIONS: 
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ANNEXURE 
SDA WITH ANTIBIOTICS [20 PG 509] 
Ingredients: 
Peptone-10gm 
Dextrose-40gm 
Agar-20gm 
Cycloheximide-500mg 
Chloramphenicol-50mg 
Gentamicin-20mg 
Distilled water-1000ml 
All the above mentioned ingredients are autoclaved and adjust pH at 
5.6. Dissolve cycloheximide in 10ml acetone and similarly dissolve 
chloramphenicol/gentamicin in 10ml of 95% alcohol and added to the boiling 
medium.Dispense in tubes ,allowed to cool in slanted position. Store at 40 C. 
shelf life of 30 days in test tube and 14 days in petridishes. 
DTM  [20 Pg 510] 
Phyton-10gm 
Dextrose-10gm 
Phenol red solution-40ml 
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8N HCl-6ml 
Actidione-500mg 
Gentamicin-100mg 
Agar-20gm 
Distilled water-1000ml 
Final pH-5.5+/-0.4 
The phenol red solution is 0.5 gm in 15ml of 1N NaOH made upto 
100ml with distilled water. Adjust pH to 5.5. 
GRAM STAIN [60] 
Crystal violet (0.5-2%)-10 gm 
Absolute alcohol (100% ethanol)-100 ml 
Distilled water-1000 ml 
Dissolve the dye in the alcohol,filter through filter paper and add to th 
water. 
Iodine solutionLugol’s) 
Iodine-10 gm 
Potassium iodide -20 gm 
Distilled water-1L 
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Add potassium iodide in 250 ml water followed sby 10 gm iodine. 
When iodine is dissolved,make up to 1 litre with water. 
Dilute carbol fuchsin: 
Basic fuchsin -5 gm 
Phenol-25 gm 
Alcohol (95% or 100%,ethanol)-50 ml 
Distilled water-500 ml 
Dissolve the fuchsin in the phenol by placing them in a 1litre flask 
over a boiling water bath for about 5min,shaking the contents from time to 
time. When solution is complete, add the alcohol and mix thoroughly. Then 
add distilled water. Filter the mixture before use. 
This Ziehl Neelsen’s stain is diluted 10-20 times its volume of water. 
LPCB   MOUNT:[20 Pg 515] 
Ingredients: 
Melted Phenol-20ml 
Lactic acid-20ml 
Glycerol-40ml 
Cotton blue-0.05gm 
Distilled water-20ml 
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Mix all ingredients properly and dissolve 0.05 gm of Cotton blue stain 
in distilled water before mixing with remaining reagents. The phenol acts as 
disinfectant. Lactic acid preserves morphology of fungi and glycerol is a 
hygroscopic agent which prevents drying. The cotton blue stains outer wall of 
fungus. 
KOH MOUNT[20 Pg516] 
Ingredients: 
Potassium hydroxide-10gm 
Glycerol-10ml 
Distilled water-80ml 
To solution of 10% KOH, 10ml glycerol is added to prevent drying. 
Mix these ingredients properly and store the solution at room temperature. 
NOTE:For 20% KOH ,20gm Potassium hydroxide is used.  
CHROM AGAR:[60] 
Ingredients: 
Glucose-20 gm 
Agar-15 gm 
Peptone-10 gm 
Chromogenic mix-2 gm 
Chloramphenicol-0.5 gm. 
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Mix all ingredients thoroughly in distilled water and make it to final 
volume of 1litre. Gently heat in a boiling water bath to dissolve components.  
After cooling to 45-500 C the media is poured into sterile petri dishes. 
 FERMENTATION OF SUGAR [20,44] 
Peptone -10 gm 
Andrade’s indicator(0.005%)-10 ml 
Sugar (Glucose,Lactose.Sucrose,Galactose,Maltose,Trehalose)-20 gm 
NaCl -0.5% 
Distilled water-1000 ml. 
Dissolve the peptone and Andrade’s indicator in 1litre of water and add 
20 gm of the sugar. Distribute in 3ml amounts in standard test tubes 
containing an inverted Durham tube. Sterilize by inspissation. 
10% YEAST EXTRACT [43] 
Yeast extract -10 gm 
Distilled water-100ml 
Mix the yeast extract and distilled water in a flask and swirl to 
dissolve. Filter sterilize the solution and store it in sterile flask in a 
refridgerator until it is used. 
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MODIFIED CHRISTENSEN’S MEDIUM FOR UREA 
HYDROLYSIS [20] 
Peptone-1 gm 
Sodium chloride-5 gm 
Disodium phosphate-1.2 gm 
Monopotassium phosphate-0.8 gm 
Phenol red -0.012 gm 
Dextrose-1.5 gm 
Agar -15  gm 
Distilled water-1000 ml. 
Urea,20%,solution,sterile-100ml 
After dissolution of the above ingredients by heat, 5 ml of phenol red 
solution (0.2% in 50 % alcohol) was added after which autoclaving was done 
at 1150 C for 15 mins. On cooling to 500 C, 100 ml of urea (20% aqueous 
solution, sterilized by filtration) was added. The medium was poured into 
slopes with the butt 1” deep and the slant 1.5” long. 
RPMI 1640(ROSEWELL PARK MEMORIAL INSTITUTE [100] 
RPMI 1640 is available in powder (without L-glutamine,L-Leucine,L-
Lysine,L-Methionine and sodium bicarbonate) 
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PROCEDURE 
To the 90% of the required final volume of distilled water, the RPMI 
1640 powder is added and gently stirred. 
Once completely dissolved the pH is adjusted to 7.2 with 1NNaOH. 
To the dissolved solution 2.0g/litre of sodium bicarbonate is added and 
stirred completely. 
The pH is adjusted 0.1-0.3 below the desired pH with 
1NHCl/1NNaOH. 
Remaining 10% of the distilled water is also added to make the final 
volume. 
The solution is sterilized immediately by filtering through membrane 
of porosity 0.22µ. 
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MASTER CHART 
S.No Age Sex DM PPBS Lesion KOH CULTURE LPCB/GRAM UREASE HAIR PERFORATION AMPHO VORI FLUCON ITRA TERBINA KETO 
1 37 F 2 150 DLSO P P T.Menta P P    S S S 
2 47 M 2 172 T.corporis N N NG         
3 38 F 2 454 T.cruris N P C.parapsil   S S S S   
4 38 F 2 243 TDO P N NG         
5 26 F 1 188 web space N P C.trpicalis   S S S S   
6 47 F 2 208 PSO P P TMENTA P P    S S S 
7 47 F 2 132 web space N P C.glabrata   S S S S   
8 62 F 2 149 WSO N P TRUBRUM      S R S 
9 48 F 2 202 TDO P N NG         
10 42 F 2 112 T.corporis P P T.Menta P P    S S S 
11 46 F 2 140 T.corporis N N NG         
12 50 F 1 169 DLSO P N NG         
13 70 M 2 206 T.corporis P P T.Menta P P    S S S 
14 50 F 2 144 DLSO N N NG         
15 85 M 2 234 T.corporis N N NG         
16 40 F 2 190 T.corporis P P T.TONS      S S S 
17 75 M 2 156 T.corporis N P T.Menta P P    S S S 
18 50 F 2 144 DLSO P P TRUBRUM      S S S 
19 50 M 2 120 WSO N P T.Menta P P    S S S 
20 47 M 2 177 DLSO N N NG         
21 56 M 2 196 web space N N NG         
22 67 F 2 184 T.corporis N N NG         
23 58 M 1 220 WSO P P C.tropica   S S S S   
24 50 F 2 144 DLSO N P C.tropica   S S S S   
25 56 M 2 194 PSO N P Rhizopus   S S  S   
26 32 M 2 204 DLSO P N NG         
27 55 M 2 223 T.manum N P T.Menta P P    S S S 
28 54 F 2 320 WSO P P CPARA   S S S S   
29 73 M 2 174 T.corporis N N NG         
30 55 M 2 113 T.corporis N P T.Menta P P    S S S 
31 77 F 1 404 TDO P N NG         
32 50 M 2 114 T.cruris P P T.Menta P P    S S S 
33 50 M 2 256 T.corporis P N NG         
34 54 F 2 330 WSO N P C.topicalis   S S S S   
35 65 F 2 104 DLSO N N NG         
36 50 M 2 114 T.corporis N P T.Menta P P    S S S 
37 50 M 2 245 PSO N N NG         
38 40 F 2 425 T.cruris N N NG         
39 42 F 2 114 DLSO P P TMENTA P P    S S S 
40 45 M 2 305 T.corporis P P T.rubrum      S S S 
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41 44 M 2 425 T.cruris N P T.rubrum      S S S 
42 45 M 2 323 DLSO N N NG         
43 74 M 2 425 WSO N N NG         
44 54 F 1 235 DLSO N P C.glabrata   S S S S   
45 56 F 2 204 DLSO P N NG         
46 60 F 2 245 T.corporis P P T.Menta P P    S S S 
47 38 M 2 123 DLSO N P c.Tropicalis   S S S S   
48 32 M 2 119 WSO N N NG         
49 64 F 2 107 DLSO P N NG         
50 55 F 2 292 T.corporis P P T.Menta P P    S S S 
51 38 M 1 235 TDO P N NG         
52 54 M 2 196 WSO N N NG         
53 59 M 2 198 DLSO N N NG         
54 59 M 2 256 DLSO N P TMENTA P P    S S S 
55 44 M 2 241 WSO P N NG         
56 65 F 2 120 T.corporis P P T.rubrum      S S S 
57 35 F 1 240 T.corporis N P T.verruco      S S S 
58 54 F 2 147 TDO P N NG         
59 42 F 2 260 T.cruris P P T.Menta P P    S S S 
60 65 F 2 208 T.cruris P P T.verruco      S S S 
61 61 F 2 237 DLSO N P T.Menta P P    S S S 
62 36 M 1 177 T.corporis N N NG         
63 45 M 2 235 T.cruris N N NG         
64 41 F 2 212 T.corporis N N NG         
65 38 F 1 180 DLSO N N NG         
66 75 M 2 270 DLSO P N NG         
67 73 M 2 126 DLSO P N NG         
68 45 M 2 260 WSO P N NG         
69 41 M 2 245 DLSO N N NG         
70 75 M 2 112 DLSO N P Fusarium   S S  S   
71 57 M 2 354 DLSO P P TMENTA P P    S S S 
72 55 M 2 187 DLSO N P Rhizopus   S S  S   
73 52 M 2 268 DLSO P N NG         
74 61 F 2 245 DLSO P P CTROPI   S S S S   
75 54 M 2 129 T.corporis P P T.Menta P P    S S S 
76 37 F 2 208 DLSO P P T.Menta P P    S S S 
77 47 M 2 132 T.corporis P N NG         
78 38 F 2 149 T.cruris N P C.TROPIC   S S S S   
79 38 F 2 202 DLSO N N NG         
80 26 F 1 120 DLSO P N NG         
81 47 F 2 240 DLSO P P A.FUMI   S S  S   
82 47 F 2 147 WSO P P C.glabrata   S S S S   
83 62 F 2 150 T.corporis N N NG         
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84 48 F 2 172 DLSO N N NG         
85 42 F 2 454 DLSO P N NG         
86 46 F 2 243 T.corporis P P T.Menta P P    S S S 
87 50 F 1 188 T.cruris P P T.rubrum      S S S 
88 70 M 2 208 DLSO N N NG         
89 50 F 2 132 T.corporis N N NG         
90 85 M 2 330 T.corporis N N NG         
91 40 F 2 174 DLSO P N NG         
92 75 M 2 113 WSO N P T.Menta P P    S S S 
93 50 F 2 177 T.corporis P P T.Menta P P    S S S 
94 50 M 2 235 WSO N N NG         
95 47 M 2 212 T.cruris P N NG         
96 56 M 2 180 T.corporis P P T.Menta P P    S S S 
97 67 F 2 196 T.corporis N P T.Menta P P    S S S 
98 58 M 1 198 DLSO P P Fusarium   S S  S   
99 50 F 2 256 WSO P P A.nidulan   S S  S   
100 56 M 2 241 DLSO N P T.Menta P P    S S S 
101 32 M 2 120 DLSO P N NG         
102 55 M 2 240 T.manum P P C.TROPI   S S S S   
103 54 F 2 147 T.corporis N N NG         
104 73 M 2 260 T.corporis N N NG         
105 55 M 2 243 WSO N P T.Menta P P    S S S 
106 77 F 1 188 T.cruris P P T.rubrum      S S S 
107 50 M 2 208 DLSO N P T.Menta P P    S S S 
108 50 M 2 132 DLSO N P C.TROPI   S S S S   
109 54 F 2 132 WSO N P Rhizopus   S S  S   
110 65 F 2 149 DLSO P N NG         
111 50 M 2 202 DLSO P P Rhizopus   S S  S   
112 50 M 2 270 DLSO N N NG         
113 40 F 2 126 T.corporis N P T.Menta P P    S S S 
114 42 F 2 260 WSO N N NG         
115 45 M 2 245 T.corporis N N NG         
116 44 M 2 112 T.facei N P T.rubrum      S S S 
117 45 M 2 174 DLSO N N NG         
118 74 M 2 113 T.corporis P P T.Menta P P    S S S 
119 54 F 1 234 T.cruris N P C.TROPI   S S S S   
120 56 F 2 190 DLSO P N NG         
121 60 F 2 156 T.barbae N P T.Menta P P    S S S 
122 38 M 2 144 DLSO P N NG         
123 32 M 2 120 T.corporis P P T.Menta P P    S S S 
124 64 F 2 177 DLSO P N NG         
125 55 F 2 243 T.pedis P P T.Menta P P    S S S 
126 38 M 1 188 T.corporis N P T.rubrum      S S S 
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127 54 M 2 208 DLSO N N NG         
128 59 M 2 132 DLSO P N NG         
129 59 M 2 425 WSO N P C.glabrata   S S S S   
130 44 M 2 323 DLSO N N NG         
131 65 F 2 425 T.pedis P P TRUBRUM      R R R 
132 35 F 1 235 DLSO N P C.TROP   S S S S   
133 54 F 2 243 DLSO N N NG         
134 42 F 2 188 WSO P N NG         
135 65 F 2 208 DLSO N N NG         
136 61 F 2 132 DLSO N P A.FUMI   S S  S   
137 36 M 1 204 DLSO N N NG         
138 45 M 2 223 WSO N N NG         
139 41 F 2 320 DLSO N N NG         
140 38 F 1 174 DLSO N N NG         
141 75 M 2 113 T.corporis N N NG         
142 73 M 2 404 T.corporis P P T.rubrum      S S S 
143 45 M 2 196 DLSO N N NG         
144 41 M 2 198 T.cruris P N NG         
145 75 M 2 245 T.corporis N N NG         
146 57 M 2 123 DLSO N N NG         
147 55 M 2 119 T.cruris P P T.Menta P P    S S S 
148 52 M 2 107 WSO N N NG         
149 61 F 2 292 T.corporis N N NG         
150 54 M 2 235 T.corporis P N NG         
M-MALE 
F-FEMALE 
PPBS-POSTPRANDIAL BLOOD SUGAR 
P-POSITIVE 
N-NEGATIVE 
NG-NO GROWTH 
S-SENSITIVE 
R-RESISTANCE 
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   Image-1   TINEA CORPORIS                       DLSO 
   
 
Image-2 KOH MOUNT-PLENTY OF ARTHROSPORES 
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TRICHOPHYTON MENTAGROPHYTES VAR MENTAGROPHYTES 
MACROSCOPY  
 
MICROSCOPY 
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TRICHOPHYTON MENTAGROPHYTES VAR INTERDIGITALE, 
MACROSCOPY  
  
MICROSCOPY 
 
 141
TRICHOPHYTON RUBRUM, MACROSCOPY 
  
Microscopy 
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T.VERRUCOSUM MACROSCOPY 
 
MICROSCOPY 
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TRICHOPHYTON TONSURANS MACROSCOPY 
 
MICROSCOPY 
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IN VITRO HAIR PERFORATION TEST-POSITIVE 
 
IN VITRO HAIR PERFORATION TEST- NEGATIVE 
 
UREA HYDROLYSIS 
 
Wedge Shaped 
Perforation 
Urease 
Positive 
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FUSARIUM SPECIES MACROSCOPY 
 
MICROSCOPY 
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ASPERGILLUS NIDULANS MACROSCOPY 
 
MICROSCOPY 
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CANDIDA TROPICALIS MACROSCOPY 
 
MICROSCOPY 
 
GERM TUBE TEST- NEGATIVE 
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CHROM AGAR-C.TROPICALIS 
 
SUGAR FERMENTATION 
 
Glucose & Sucrose-Fermented  
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CHROM AGAR-C.PARAPSILOSIS 
 
 
SUGAR FERMENTATION 
  
Glucose Fermented  
 150
CHROM AGAR-C.GLABRATA 
 
SUGAR FERMENTATION 
 
Glucose Fermented  
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MIC OF ITRACONAZOLE - DERMATOPHYTE 
 
Arrows shows Resisstant Strain- T.rubrum 
MIC OF TERBINAFINE - DERMATOPHYTE 
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Image-19MIC OF AMPHOTERICIN B - NON DERMATOPHYTE 
MOULDS 
 
 
Image-20  MIC OF FLUCONAZOLE-CANDIDA SPECIES 
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